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The formation of functional epithelial tissues involves the coordinated action of several protein complexes, which together produce a cell
polarity axis and develop cell–cell junctions. During the last decade, the notion of polarity complexes emerged as the result of genetic studies in
which a set of genes was discovered first in Caenorhabditis elegans and then in Drosophila melanogaster. In epithelial cells, these complexes are
responsible for the development of the apico-basal axis and for the construction and maintenance of apical junctions. In this review, we focus on
apical polarity complexes, namely the PAR3/PAR6/aPKC complex and the CRUMBS/PALS1/PATJ complex, which are conserved between
species and along with a lateral complex, the SCRIBBLE/DLG/LGL complex, are crucial to the formation of apical junctions such as tight
junctions in mammalian epithelial cells. The exact mechanisms underlying their tight junction construction and maintenance activities are poorly
understood, and it is proposed to focus in this review on establishing how these apical polarity complexes might regulate epithelial cell
morphogenesis and functions. In particular, we will present the latest findings on how these complexes regulate epithelial homeostasis.
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Cell polarity, which is fundamental to many aspects of cell
and developmental biology, is involved in the processes of
differentiation, proliferation and morphogenesis in both unicel-
lular and multicellular organisms. In a wide range of elementary
cellular processes, many constituents of the cell, such as plasma
membrane proteins, organelles, and cytoskeletal components
are organized asymmetrically within the cell. This asymmetrical
pattern of organization is enhanced by cell differentiation
processes resulting in dynamic cell compartments specialized in
complex vectorial functions. Cell polarity is essential for
processes such as the growth of budding yeast [1], cell division
[2], the development of a fertilized egg into an organism [3], the
transmission of nerve impulses [4], the transport of molecules
across an epithelial cell layer [5], cell crawling [6] and lym-
phocyte homing [7], etc. Transient or stable cell polarization
therefore constitutes a universal cellular trait in most multicel-
lular organisms. One of the main challenges arising in this field
during the last 15 years has been finding common molecular
denominators between all these cellular events and processes,
which may look very different in some respects but are all based
on the development of cell polarity. Studies on these lines have
led to the discovery of three polarity protein complexes that are
all essential to epithelial polarity. In this review, it is proposed to
report on how these complexes were discovered and to describe
the structure of their components, focusing on the mammalian
epithelial cells and tight junctions. The polarity of epithelial
cells results in the presence of at least two plasma membrane
domains: the apical surface facing the external medium and the
basolateral surface connected to adjacent cells and connective
tissue. The protein and lipid composition of these domains
differs, reflecting their specific functions. Tight junctions
provide a physical border between apical and lateral domains
but their exact role in establishing and/or in maintaining this
epithelial cell membrane asymmetry is still under debate.
The newly identified partners at work in polarity protein com-
plexes will be reviewed here, as well as the connections be-
tween them.2. Genetic analysis of polarity complexes
Model organisms such as Caenorhabditis elegans and Dro-
sophila melanogaster provide useful means of describing basic
biological processes. They lend themselves particularly well to
addressing some of the questions arising in this field because of
their structural simplicity and stereotyped features. In addition,
their genomes have been completely sequenced and large-scale
genetic screens are easy to perform. Genetic studies have shown
the existence of evolutionarily conserved and ubiquitously
expressed proteins that regulate cell polarization in many dif-
ferent cellular contexts (Table 1).
2.1. Par complex discovery
The first genes involved in cell polarization were identified by
Kemphues et al. in 1988 [8], based on the asymmetric divisions
occurring in the C. elegans zygote. After the fertilization step,
zygotic asymmetric divisions leading to the formation of the
germline contribute importantly to embryonic patterns of
organization [9]. Each of these divisions is asymmetric, producing
daughter cells differing in their size, cell division timing, cleavage
pattern, and ultimate fate. In addition, the germline-specific
P granules (ribonucleoprotein particles) are located at one pole of
the cell prior to each division partition into the smaller daughter
cells [10,11]. By performing genetic screens to detect maternal-
effect lethal mutations disrupting these asymmetries, Kemphues
et al. identified six genes called par (for partition defective) [8].
These mutations lead to abnormalities in the cleavage pattern, its
timing and the distribution of P granules. Par proteins are
therefore essential to the partitioning of early determinants and the
development of polarity. Based on sequence analysis Par1 and
Par4 were predicted to be protein kinases [12,13], while Par3 and
Par6 contain PDZ (PSD-95, discs large, ZO-1) domains [14,15],
Par5 is a 14.3.3 protein [16], and Par2 is a protein containing a
zinc-binding domain of the ring finger class [17]. Par2 has no
homologues in other species as far as we know. In line with their
role in polarity, many of the Par proteins are asymmetrically
distributed in the C. elegans one-cell embryo: Par1 and Par2 are
Table 1









Aliases and previous symbols K location Isoforms MW (kDa)
unprocessed (4)
Par6/Par3/aPkc complex DmPar6 – PARD6A PAR6; PAR6A; TIP40; PAR6α; PAR6C 16q22 2 37
– PARD6B PAR6B 20q13 1 41
Par-6 PARD6G PAR6G; Par6γ; PAR6D 18q23 1 41
Bazooka – PARD3 PAR3A; PAR3; PAR3α; ASIP; CTCL 10p11 10 180
Tumor antigen se 2–5
Par-3 PARD3B PAR3β; PAR3L; ALS 2CR 19 2q33 5 140
DmaPkc PKC-3 PRKCi PKCI; nPKCι; aPKCι/λ; PRKCι/λ 3q26 1 67
– PRKCz PKC2; nPKCζ 1p36 1 68
Crb/Pals/Patj complex Crb Crb1 CRB1 RP12; LCA8 1q31–q32 4 154
Eat-20 CRB2 9q33 3 134
– CRB3 19p13 2 13
– MPP1 EMP55 Xq28 1 52
– MPP2 DLG2 17q12–q21 3 65
– MPP3 DLG3 17q12–q21 1 66
– MPP4 DLG6 2q33 5 73
Sdt TAG-117 MPP5 Pals1 14q23 2 77
C50F2.8 MPP6 Pals2; VAM-1; p55T 7p15 1 61
Y55B1BR.4 MPP7 10p12 1 65
Dpatj* – INADL PATJ 1p31 5 196
MPZ-1 MPDZ MUPP1 9p24–p22 3 219
Scrib/Dlg/Lgl complex Scrib LET-413 SCRIB SCRB1; CRIB1; Vartul; LAP4 8q24 4 175
Dlg dlg-1 DLG1 SAP97; hDlg 3q29 7 100
– DLG2 PSD-93; Chapsyn110 11q21 4 97
– DLG3 SAP102; NE-DLG Xq13 1 90
– DLG4 PSD95; SAP90 17p13 2 80
F44D12.1 DLG5 P-DLG 10q23 2 202
Dlgl – (5) LLGL1 L2GL1; DLG4; HUGL1; LGL1 17p11 1 115
– LLGL2 L2GL2; HGL; LGL2 17q24–q25 3 113
(1) Source: http://www.wormbase.org/, C. elegans orthologs obtained after a blast search with human protein sequences in the worm base. (2) Source: http://www.
gene.ucl.ac.uk/cgi-bin/nomenclature/searchgenes.pl. (3) Source: http://www.expasy.org/. (4) Molecular weight of the amino acid sequence of the longest isoform in
kiloDaltons (kDa). (5) Only one ortholog of the LGL-related protein family, Tomosyn (Tom-1), has been found to exist so far in C. elegans. (–) No orthologs were
found in the database. *old name: Dlt.
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cortex, while Par4 and Par5 are diffused throughout the
cytoplasm. The par genes provide the polarity information
required during the first cell cycle for cell-fate regulators to be
properly asymmetrically distributed (reviewed in [18]). The
proper distribution of Par1 requires the presence of the actin
cytoskeleton and the non-muscle myosin, NMY-2, which
interacts directly with a C-terminal region of Par1 [19]. Depletion
of NMY-2 by RNA interference leads to par-like phenotypes
in C. elegans embryos [19]. Par3 contributes to determine the
restricted patterns of distribution of Par1 and Par2, because these
proteins are uniformly present in par3mutants at the periphery of
the embryo [15,20]. In 1996, Watts et al. [21] suggested that Par6
may act via Par3 by targeting or maintaining the Par3 protein at
the cell periphery in C. elegans early embryos. These genetic
analyses show that the localizations of Par proteins result from
interdependent processes, although these proteins act together in a
common process, which still remains to be identified. Two years
later, Tabuse et al. [22] discovered a seventh par gene coding for
an atypical protein kinase C (PKC3). Embryos lacking PKC3 as
the result of RNA interference die, showing par3-like phenotypes
[22]. Par3 and PKC3 proteins, which are colocalized in earlyC. elegans embryos, interact physically in vitro and are mutually
dependent in terms of their asymmetric peripheral localization
[22]. The concept of the first polarity protein complex, Par6/Par3/
PKC3, was born.
2.2. Crb complex discovery
In 1990, Tepass et al. [23] established the existence of a link
between epithelial polarity and crumbs (crb), a gene previously
identified by Jürgens et al. [24] in D. melanogaster. The
structure of the embryonic cuticle reflects the organization of the
underlying epithelial epidermis from which it is secreted. Crb
mutations are characterized by severe disruption of the cuticle
(hence the name crumbs) and the epithelia originating from the
ectoderm and extensive cell death in the epidermal primordium
[23]. In the Drosophila embryo, the first cleavages occur in the
absence of cytokinesis, giving rise to the syncytial blastoderm.
Cellularization results from the invagination of plasma mem-
branes to form the membrane furrow (reviewed in [25]).
Cellularization of Drosophila embryo results in the formation
of a cell monolayer showing many of the characteristics of
polarized epithelia. In epithelial cells of Drosophila embryos at
617E. Assémat et al. / Biochimica et Biophysica Acta 1778 (2008) 614–630later stages, the lateral plasma membrane consists of three
distinct domains. The most apical domain comprises the
subapical complex. It is followed by the zonula adherens, and
further basally, by the septate junction. Embryos with crumbs
mutations fail to assemble or stabilize a zonula adherens from
spot adherens junctions [23]. This leads to the loss of cell
polarity and adhesion, followed by breakdown of the epithelial
structure and extensive cell death.
In epithelial cells, Crumbs (Crb) is found exclusively in the
apical membranes and at the border between cells [23]. The
Drosophila crb gene encodes an integral membrane protein
(200 kDa) with a large extracellular part composed of 29 EGF-
like and 3 laminin A/G domain-like repeats and a short
cytoplasmic region of 37 amino acids [23]. This small domain is
crucial for Crb function, since a stop mutation (crb8F105) in this
domain leads to a complete loss of function [26]. Conversely,
overexpression of Crb results in the expansion of the apical
plasma membrane and a concomitant decrease in the basolateral
domain [27], and transforms the single-layered epidermis into
a multilayered tissue [28]. In parallel there is a redistribution of
β-Heavy-spectrin, a component of the membrane cytoskeleton
[27]. Indeed Medina et al. have shown that the cytoplasmic
domain of Crb links directly the β-Heavy-spectrin in Droso-
phila ectodermal cells [29]. Crb therefore plays a key role in
specifying the apical plasma membrane domain of ectodermal
epithelial cells of Drosophila. In 1993, Tepass and Knust [30]
observed that the developmental defects caused by stardust
(sdt) mutations were very similar to those associated with crb
mutations. Studies on double mutant combinations of crb and
sdt suggested that these genes may be part of a common
genetic pathway (the crb/sdt pathway) in which sdt acts
downstream of crb and is activated by the latter [30,31]. Sdt
encodes a MAGUK (membrane-associated guanylate kinase)
protein containing a single PDZ domain, a SH3 (Src homology
region 3) domain and a GUK (homologous to the known
guanylate kinases without enzymatic activity) domain [32], and
as the result of alternative splicing, at least two isoforms of Sdt
exist in Drosophila. Sdt binds to the four C-terminal amino
acids of Crb via its PDZ domain [32,33].
In 1999, Bhat et al. [34] characterized a new protein
containing four PDZ domains (called Disc Lost) that interacts
with Crb and is essential for epithelial cell polarity. In fact,
subsequent studies have shown that dlt locus encoded several
genes. Mutations corresponding to the dlt phenotype disrupt
Drosophila Codanin-1 homologue, a cytoplasmic protein, and
not the formerly identified PDZ protein [35], which is now
known as Dpatj. While Pielage et al. [35] reported that Dpatj
mutations had no polarity phenotype, a recent study has shown
that a truncated Dpatj protein containing the first two PDZ
domains was still expressed and that a null allele indeed showed
polarity defects in the early embryo [36]. These data confirmed
those obtained upon removing Dpatj (using RNA interference
methods) prior to the process of cellularization, which induced
the complete loss of polarity, as shown by the pattern of Crb
distribution [34]. Dpatj is a component of the Crb complex in
Drosophila embryos [28,37] as well as adult flies [38]. By
analogy with vertebrates, it has been suggested that the L27(Lin2 Lin7 binding) domain of Dpatj may bind to the N-terminal
L27 domain of Sdt. It has therefore emerged that Crb, Sdt and
Dpatj form the second polarity complex.
2.3. Scrib complex discovery
The scribble (scrib) gene was identified in Drosophila using
a screen for maternal mutations disrupting aspects of epithelial
morphogenesis such as cell adhesion, shape and polarity [39].
The wild-type embryonic cuticle was found to have smooth,
continuous sheet cuticles, whereas the scrib mutant embryos
produce a corrugated cuticular surface that is riddled with holes
(hence the name scribble) [39]. Scrib mutations cause broad
defects in the epithelial organization leading to cells that are
rounded, irregularly shaped and piled upon each other. The
scrib gene encodes for a protein of 195 kDa with 16 leucine-
rich repeats (LRR) and four PDZ domains, belonging to the
LAP (LRR and PDZ) protein family [40].
The pattern of distribution of Scrib evolves from basal
membranes to the zonula adherens at early embryonic stages,
and it later targets the septate junction in mature epithelial cells.
In scrib mutants, the polarity defects of epithelial cells do not
result from the total loss of cell polarity but from a specific
misdistribution of apical proteins. In scrib mutant, for example,
apico-lateral markers such as Crb, Dpatj, E-cadherin and
Armadillo are distributed throughout the plasma membrane of
epithelial cells [39]. By contrast, basolateral markers such as
β spectrin keep their restrictive localization. These findings
indicate that one of the main functions of Scrib in epithelial
polarity consists in excluding apical proteins (like the Crb
complex) from the basolateral domain [39]. Bilder et al. [41]
established the existence of correlations between two other
genes, lethal giant larvae (lgl) and lethal discs large (dlg),
which give the same embryonic phenotype as scribmutant when
they are mutated. These two genes were initially identified as
tumor suppressors, because mutations resulted in tissue-specific
tumors in larvae and their death, hence their names [42,43].
Mutated lgl affects cell growth and the cell adhesion
properties of neural and imaginal disc cells during embryonic
and larval development [44]. Lgl is a 130-kDa protein showing
short motifs with sequence similarities with proteins having cell
adhesion properties [45]. These short motifs are WD repeats
consisting of approximately 40 amino acids and often ending in
a Trp-Asp (W-D) dipeptide.
Mutations in the dlg tumor suppressor gene of Drosophila
lead to neoplastic overgrowth of the imaginal discs [46]. Dlg is a
102-kDa protein and its amino acid sequence includes a core
arrangement of several domains which are conserved in other
MAGUK proteins: a L27 domain, a GUK domain, a SH3 motif,
and three PDZ domains [46]. PDZ sequences [47] have pre-
viously been described as GLGF repeats [48] and Dlg
Homology region domains [49].
The Lgl and Dlg proteins are located in an apical belt in the
lateral cell membrane, at the septate junction. Scrib and Dlg
overlap with Lgl in epithelial cells [41]. It has been suggested
that these three proteins, Dlg, Lgl, and Scrib, which show
common patterns of distribution and “loss of function”
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biochemical complex that controls and refines the segregation of
apical and basolateral membrane domains, although no physical
interactions occur between them [39,41].
3. Polarity complex composition and interactions
3.1. Mammalian PAR complex
The PAR complex initially described in the nematode
C. elegans and later in the fruit fly D. melanogaster and
vertebrates is composed of two scaffold proteins, PAR6 and
PAR3 and an atypical protein kinase C, aPKC (Table 1). This
tripartite complex named PAR6/PAR3/aPKC is conserved from
worms to vertebrates. PAR6, PAR3 and aPKC were first
described as essential proteins for asymmetric division of the
C. elegans zygote [21,50].
3.1.1. PAR6
Three PAR6 proteins encoded by three different genes have
been identified in mammals: PAR6A/C, PAR6B and PAR6D/G
(Table 1). All three have a similar molecular weight (37 kDa),
function as part of a protein complex and contain three
conserved domains mediating their interactions with the other
members of the complex (Fig. 1). A Phox/Bem 1 (PB1) domain
that binds to other PB1-domain-containing proteins such as
aPKC is located at the N-terminal. The adjacent Cdc42/Rac
interaction binding (CRIB) motif binds to the Cdc42 or Rac
GTPases only in their activated GTP-bound state (reviewed in
[51]). Lastly, all three have a PDZ domain that binds to other
proteins such as PAR3 and CRB3 [52–55].
Although the three PAR6 proteins are structurally similar,
they have different patterns of tissue and subcellular distribu-
tion. PAR6G is widely expressed, showing higher levels of
expression in the kidney than elsewhere, and PAR6A and B
show more restricted patterns with higher levels of expression
(for details, see [52]; the authors used different nomenclature for
the PAR6 compared to the database search genes: PAR6A is
PAR6G, PAR6B is PAR6B and PAR6C is PAR6A). PAR6A and
B are both present in the pancreas, kidney and placenta, but
show different patterns of lung and liver expression, and
PAR6A alone is also found in the skeletal muscle, brain and
heart. A difference was recently reported in mammals between
the patterns of expression of PAR6A and B in the oocytes
during mouse embryonic development [56]. Louvet-Vallee et al.
[57] have reported that PAR6A is only detected at the 2-cell
stage, whereas PAR6B is expressed from the 2-cell to blastocyst
stage [58]. In addition, before cell compaction occurs, PAR6B is
located only in nuclei, and after the compaction PAR6B is
targeted the apical pole of the 8-cell stage blastomere [58]. This
is also the case in epithelial MDCK cells, where PAR6 proteins
show different patterns of distribution [59]. PAR6A is present in
both at tight junctions and in the cytosol, whereas PAR6B is
localized to the cytosol; whereas PAR6G predominantly colo-
calizes with tight junction markers [59]. The specific spatio-
temporal localizations for each PAR6 proteins strongly suggest
different functions.We will focus on the function of PAR6 in epithelial cells.
Since PAR6 proteins do not include enzymatic domains, they
function by bringing together several proteins at a specific
localization (tight junctions, the leading edge of a migrating
cell, the tip of the growing axon, etc.) (reviewed in [60]). It has
been reported that in mammalian epithelial cells, overexpres-
sion of PAR6B delays the formation of tight junctions without
affecting the adherens junctions [61], and that when PAR6B is
overexpressed in cells already polarized, the tight junctions are
disrupted [52,62]. Interestingly, Joberty et al. [52] reported that
the PDZ domain of PAR6B is sufficient to disrupt tight
junctions. Surprisingly, PAR6G, which is known to be asso-
ciated with tight junctions, does not affect these junctions
when it is overexpressed [59]. Although the PDZ domains are
very similar between PAR6B and G, they do not bind with the
same affinity to PALS1 [59,63], a protein known to be tightly
associated with tight junctions. When PAR6B is overex-
pressed, it may take PALS1 away from the junctions; PAR6B
binding to PALS1 can in fact interfere with PATJ binding to
PALS1, and these interactions do not work synergistically
[63].
The exact function of PAR6 has not yet been elucidated, but
since Garrard et al. [64] established that Cdc42-GTP can induce
a conformational change in PAR6B, Gao and Macara [59]
developed a functional model for PAR6, in which the N-terminal
folds back and interacts with the CRIB-PDZ domain. Cdc42-
GTP binding to PAR6 [65] results in the unfolding of PAR6B
and A, thus exposing the PALS1 binding site (PDZ domain in
PAR6), whereas in PAR6G, this domain is too stable to be
released.
The key function of PAR6 is to allow the interaction between
aPKC and its downstream effectors such as PAR3 and LGL
(described in (Sections 3.1.2, 3.1.3, and 3.3.3)) [66]. Phosphor-
ylation of LGL will result in its detachment from the aPKC/
PAR6 dimer, leading to the formation of another functional
complex: PAR6/PAR3/aPKC [66].
3.1.2. PAR3
Two PAR3 genes, PAR3A and PAR3B, have been identified in
mammals (Table 1). PAR3A encodes three proteins with different
molecular weights (180 kDa, 150 kDa, 100 kDa). All the PAR3A
protein isoforms contain three PDZ domains (Fig. 1) and only
the shortest isoform lacks the aPKC binding region. The first
PDZ of PAR3A interacts with PAR6 [54]. PAR3B proteins
(140 kDa) include a region which is homologous to the aPKC-
binding domain, as well as the three PDZ domains. Strikingly,
PAR3B does not seem to interact with aPKC [67,68], and its
interaction with PAR6 is still not clearly understood. PAR3A is
widely expressed in various tissues, showing higher levels of
expression in the heart, kidney (where all three isoforms are
present), and brain (where the 180-kDa and 150-kDa isoforms
are present) [54]. During mouse embryonic development,
PAR3A 180-kDa and 100-kDa isoforms are expressed earlier
than the 150-kDa isoforms. The last one can be detected from
day 14.5 of development onwards. PAR3B is strongly expressed
in the kidney, lung and skeletal muscle and in lower levels in the
brain heart, liver and pancreas. PAR3A and PAR3B are partially
Fig. 1. Structure and interactions of mammalian polarity complex proteins. (Part A) PAR complex, (part B) CRB complex and (part C) SCRIB complex. Domains are
shown according to the SMART (Simple Modular Architecture Research Tool) database (http://smart.embl-heidelberg.de.). All interactors are mentioned in the text
except for TβR1 (TGFβ receptor 1) [182], Smurf [182], Ect2 [183], KIF3A [184], MASCOT [166], JEAP [166], CamKII [185], TAPP1/2 [186], TARPs [187],
synGAP [185], dopamine receptor [188], Vangl2 [128], Shaker K+ channel [189].
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tight junctions [65,67–69].
PAR3A has been extensively studied in epithelial cells. It
seems likely that the starting point required for PAR3A to target
the tight junctions is its ability to form self-associations and to
bind to the junctional adhesion molecules (JAMs). PAR3A
forms a homodimer via its N-terminal region; this associationseems to be required for the correct association of PAR3A at the
apical side of the cell–cell contact region during the process of
polarization [70]. This mechanism may also be adopted by
PAR3B [52]. PAR3A may then be stabilized upon binding
directly to JAM via its first PDZ domain, and these two proteins
may then be co-distributed to the sites of cell–cell contact [71].
As JAMs are present at newly formed cell–cell contacts prior to
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to the junctional complex at an early stage in the junction
formation process [72]. Once PAR3A occupies this site, it can
play the role of a scaffold in the recruitment of proteins involved
in the formation of the junctions, such as PAR6 [52] or aPKC
[73]. Many studies have in fact shown that overexpression or
depletion of PAR3A in epithelial cells leads to the disruption of
tight junctions, along with the mislocalization of PAR6, aPKC
and tight junction markers [52,69,70,74].
PAR3A interacts with members of the PAR complex and
with other proteins such as 14.3.3 [75], LIMK2 [76,77], Tiam1
(reviewed in [78]) and certainly with other unknown partners.
These interactions seem to be dependent on the state of
phosphorylation of PAR3 [75,76], which is partially regulated
by aPKC. The mechanisms underlying these different interac-
tions suggest that PAR3A may be involved in the regulation of
the dynamics of the cytoskeleton (reviewed in [78]).
3.1.3. aPKC
In mammals, two aPKC genes, aPKCλ/ι and aPKCζ en-
coding two different proteins have been identified (Table 1) [79,
80]. They have similar molecular weights (75 kDa) and function
as part of the polarity complex PAR (reviewed in [51]). Unlike
conventional PKCs, aPKCλ/ι and aPKCζ are unique in having
a PB1 domain in the N-terminal, which is known to interact
with PAR6. The lack of a C2 domain and the incomplete C1
domain prevent aPKCλ/ι and aPKCζ from being activated by
Ca++, diacyl-glycerol and phorbol esters in the same way as
classical PKCs [81]. The only domain conserved among PKC
proteins is the catalytic domain present within the C-terminal
region [82,83] (Fig. 1). This domain is known to phosphorylate
several proteins such as PAR3 [84] and LGL [85]. In addition,
Yamanaka et al. [66] have demonstrated that both LGL and
PAR3 can form independent complexes with aPKC/PAR6 to
regulate epithelial cell polarity.
aPKCλ/ι and aPKCζ are strongly expressed in the lung and
brain, and the latter protein is also present in the kidney and
testis. Many studies have been performed on epithelial cells,
where both isoforms are expressed, but the data available so far
do not point to the existence of any specific function for one or
other isoform.Wewill therefore not distinguish here between the
two isoforms.
In MDCK epithelial cells, aPKCs localize with the other
members of the PAR complex at tight junctions [69]; and it is
worth noting that aPKCs are the only members of the complex
showing catalytic activity. This kinase activity is required for
the formation of tight junctions to occur, as overexpression of
kinase-dead aPKC mutant blocks their formation, and leads to
mislocalization of PAR6 and PAR3 [73]. The results of several
studies have led to the conclusion that the interaction between
the N-terminal regions of PAR6 and aPKC is constitutive in
epithelial cells [86]. As Cdc42-GTP binds to PAR6, it seems
likely that Cdc42-GTP may form a complex with aPKC via the
adaptor PAR6. Noda et al. [86] have established that the
expression of Cdc42-GTP leads to the translocation of aPKC
from the nucleus to the cytoplasm and cell periphery, where the
complex will be involved in tight junction formation. Cdc42 isactivated upon E-cadherin mediated cell–cell adhesion [87],
resulting in phosphorylation and thus activation of aPKC, and
this chain of events is crucial to tight junction formation [88,89].
3.2. Mammalian CRB complex
The Crumbs complex was identified in the epithelia of
Drosophila and subsequently in vertebrates (Table 1). Mam-
malian CRB are transmembrane proteins, whereas the other
proteins present in this complex, PALS1 and PATJ, are cyto-
plasmic scaffolding proteins.
3.2.1. CRB
Although there is only one crumbs gene in D. melanogaster,
three genes denoted CRB1, 2, and 3 have been identified in
mammals, and their products have been detected in expressed
sequence tag (EST) databases [90].CRB1 and CRB2 are mainly
expressed in the retina and brain [91] and CRB2 is also present
in the kidney [92]. CRB3 is mainly expressed in skeletal
muscles and in all epithelial tissues [53,93,94]. These localiza-
tions suggest the existence of a tissue-related functional spe-
cialization of CRB proteins in mammals.
In their extracellular domains, CRB1 (154 kDa) and CRB2
(134 kDa) consist of 3 Laminin A/G domains and 19 and 14
EGF-like domains, respectively [95,96] (Fig. 1). CRB3 (13 kDa)
on the contrary has a very short extracellular domain but no
recognizable protein domain and includes O andN glycosylation
sites [90] (Fig. 1). These 3 proteins have a transmembrane
domain and a cytoplasmic domain very well conserved,
although different splice variants of CRB1 and CRB2 encoding
secreted proteins lacking the transmembrane and intracellular
domains have been described [92,95–97].
CRB1 mutations are responsible for retinal diseases, Leber
congenital amaurosis (LCA) and retinitis pigmentosa (RP)
[91,95]. It has been suggested that CRB1may contribute to these
disorders by impairing cell adhesion properties or the formation
of the apical surface [91,95]. Despite the high degree of
similarity existing between the structure and patterns of
expression of CRB1 and CRB2, CRB2 has not been found to
be involved in these pathologies [92]. The function of CRB2 is
not clearly understood yet.
CRB1, CRB2 and CRB3 have a very similar cytoplasmic
domain showing 63%, 68% and 54% identity with Drosophila
Crumbs, respectively [98,99]. In their cytoplasmic tails, CRB
proteins contain two motives: a FERM (band 4.1-ezrin-radixin-
moesin) protein-binding domain consisting of 12 amino acids
containing a GTY motif [28,100] and a PDZ-binding domain
consisting of ERLI residues [53,55]. The FERM domain is a
protein–protein interaction domain which exists in various
proteins, many of which serve as adapters linking trans-
membrane proteins to the cortical actin cytoskeleton [101].
The FERM domain is involved in recruiting a Dmoesin and
β-Heavy-spectrin network in Drosophila ectodermal cells [29].
CRB3 has an additional SH3 binding site (consisting of PxxP
residues), which has not been found to exist in any other CRB
[53,102], and may mediate the involvement of CRB3 in specific
pathways.
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sophila, and many studies have shown during the last few years
that it plays a similar role in mammals. Fogg et al. [93] have
shown that loss of the ERLI sequence or point mutations in the
FERM binding motif severely affects the ability of CRB3 to
induce tight junctions in human epithelial MCF10A cells, while
the SH3 binding motif is not involved in this process.
Overexpression of CRB3 in MDCK cells delays the formation
of tight junctions, and this effect depends on the last four ERLI
residues of CRB3 [53,103].
In addition to playing a role in the formation of tight
junctions, CRB3 is involved in the differentiation of the apical
membrane. Fan et al. [104] have shown, for example, that in
addition to its previously observed presence at apical and tight
junctions, CRB3 is also present in discreet puncta in the primary
cilia of MDCK. The authors have established that CRB3
contributes to cilium formation, since downregulation of CRB3
expression resulted in the inability of MDCK cells to form cilia
[104].
3.2.2. PALS1
PALS1, also known as membrane-associated palmitoylated
protein 5 (MPP5), is the mammalian homologue of the
Drosophila Sdt protein. PALS1 was first cloned as a new
binding partner for Lin7 [105]. Roh et al. [106] have
established that PALS1 is an adaptor protein mediating
indirect interactions between CRB and PATJ. High levels of
PALS1 mRNA expression have been detected in the placenta
and kidney, and moderate levels in the brain, heart and skeletal
muscle [105].
PALS1 (77 kDa) is a scaffold protein that has multiple
protein–protein interaction domains and belongs to the
MAGUK (membrane-associated guanylate kinase) family
[105] (Fig. 1). PALS1 consists of two L27 domains, a PDZ
domain, an SH3 domain, a hook domain and a GUK domain
[32,33,105]. The function of the SH3 domain and GUK domain
of PALS1 still remains to be established. However, extensive
intramolecular interactions have been found to occur between
SH3 domain and GUK domain in MAGUK proteins [107,108].
In mammals, PALS1 interacts directly via its PDZ domain
with the ERLI motif of the cytoplasmic domain of CRB1 [106].
PALS1 was the only interactor identified in a yeast two-hybrid
screen performed on a retinal cDNA library using the
intracellular domain of CRB1 as bait [106]. CRB3 is also linked
to the PDZ domain of PALS1 [94]. In addition, the first L27
domain interacts with PATJ and the second with Lin7. Knock
down of PALS1 in MDCK cells leads to tight junction and
polarity defects [109] and to the mis-targeting of E-cadherin to
the cell membrane [110]. Furthermore, loss of PALS1 resulted in
concomitant loss of PATJ expression, but had apparently no
effect on CRB3 expression or distribution [109,110]. It is not yet
known whether the absence of PALS1 affects PATJ expression
via the transcription, translation or stability of the protein. Since
the presence of PALS1 in mammalian epithelia depends on
interactions with PATJ [111], it seems possible that the stability
of these two proteins may depend on interactions between them
[109].3.2.3. PATJ/MUPP1
There exist two mammalian homologues of the Drosophila
Dpatj: PATJ (Pals-associated tight junction protein) [37], which
is also known as human InaD-like (inactivation no after-
potential D) [112], and MUPP1 (multi-PDZ domain protein)
[113] (Table 1).
3.2.3.1. PATJ. PALS1 can bind to PATJ, a multiple PDZ
domain containing protein localized at tight junctions. PATJ
(196 kDa) expression has been found to occur mainly in ep-
ithelial tissues: bladder, testis, ovary, small intestine, colon,
heart, pancreas, kidney, and lung, as well as the brain and skel-
etal muscle [99,112].
The interactions between PALS1 and PATJ involve the
binding of the first L27 domain of PALS1 to L27 domain of
PATJ (domain also called Maguk Recruitment: MRE) [106].
The PATJ L27 domain present at the N-terminal is followed by
up to ten PDZ domains [37,99] (Fig. 1). The 6th and 8th PDZ
modules of PATJ interact directly with ZO3 and Claudin1,
respectively, via the PDZ-binding domain present at the C-
terminal ends of these proteins [37]. The ZO3 cytoplasmic
protein is linked to tight junctions via its association with
Occludin [114]. It is worth noting that Occludin and Claudin1
are transmembrane proteins that constitute the basic architec-
ture of tight junctions. The fact that overexpression or
downregulation of PATJ in epithelial cells disrupts the tight
junction-specific localization of ZO1, ZO3 and Occludin,
suggests that PATJ might be involved in stabilizing tight
junctions [99,111,115]. The downregulation of PATJ also
affects the distribution of the other CRB complex proteins,
CRB3 and PALS1, which were no longer accumulated at the
apical membrane and at tight junctions [111]. These data
strongly suggest that PATJ provides a link between the lateral
(Occludin and ZO3) and apical (PALS1 and CRB3) compo-
nents of tight junctions and stabilizes the CRB3 complex
[37,111].
3.2.3.2. MUPP1. MUPP1 (219 kDa) was originally identi-
fied as a protein that interacts with the C-terminal of the sero-
tonin 5-hydroxytryptamine type 2 receptor [113]. MUPP1 has a
L27 domain in its N-terminal and 13 PDZ domains (Fig. 1).
MUPP1 and PATJ PDZ domains show high levels of homology
and bind to some identical proteins. For example, PDZ 10 of
MUPP1 and PDZ 8 of PATJ show 78% homology and both
bind to Claudin1. MUPP1 is concentrated at tight junctions
[116,117] and has been detected in the heart, brain, placenta,
liver, skeletal muscle, kidney and pancreas [113].
MUPP1 interacts with several molecules via its PDZ
domains. Although its functional characteristics in epithelial
cells have not yet been addressed, MUPP1 may act as a scaffold
for several tight junction components, since a number of tight
junction proteins have been found to bind to MUPP1, including
JAM and CAR (coxsackievirus and adenovirus receptor), as
well as Claudins [116–119]. MUPP1 may serve as a cross-
linker in tight junctions between Claudin-based tight junction
strands and JAM oligomers. However, the occurrence of 13
PDZ domains in tandem within single MUPP1 molecules might
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be tethered to the tight junction via MUPP1 molecules.
MUPP1 is linked to the CRB complex, since its L27 domain
binds to PALS1. Roh et al. [103,106] have established that
PALS1 binds to the L27-like domain of PATJ and MUPP1, and
that PALS1 binds to CRB1. Studies based on the immunopre-
cipitation of MUPP1 from retinal lysates recently showed that
endogenous MUPP1 interacted in photoreceptor cells in a
protein complex with CRB1, PALS1 and MPP4, in agreement
with the finding that CRB1 and MUPP1 are colocalized in the
retina [120]. In CRB1−/− retinas before the onset of retinal
degeneration, the complex consisting of MUPP1, PALS1 and
MPP4 was formed in the absence of CRB1, which indicates that
CRB1 is not essential to this interaction. MAGUK proteins may
form heterodimers or homodimers [121], and indeed it has been
reported that MPP4 interacts with PALS1 [122]. All these data
suggest that in photoreceptor cells CRB1/PALS1-MPP4/
MUPP1 complexes are probably present. Since PATJ is also
colocalized with CRB1 and MUPP1 at the subapical region, it is
conceivable that CRB1/PALS1-MPP4/PATJ complexes may
also exist.
3.3. Mammalian SCRIB complex
Mammalian SCRIB, LGL and DLG show similar sequences
and functions to those of their Drosophila homologues
(Table 1). SCRIB, LGL and DLG are localized in the basolateral
domain of epithelial cells [123–125]. The exact nature of the
physical interactions between SCRIB, LGL and DLG has not yet
been clearly defined. In Drosophila neuronal synapses, Scrib
associates physically with Dlg via a protein termed GUKHolder
[126], which was recently characterized in humans [127], and
physical interactions between SCRIB and LGL2 were recently
found to occur in polarized mammalian epithelial cells [128].
3.3.1. SCRIB
The only homologue of Drosophila Scrib described so far in
mammals [129,130], which is also known as VARTUL, was
first isolated in a biochemical screen designed to identify the
proteins targeted by the E6 oncoprotein of the human papilloma
tumor virus (HPV), the main agent responsible for cervical
cancer [129]. The expression levels of SCRIB protein are low in
the kidney, skeletal muscles, liver and lung and high in the
breast, intestine, placenta and skin [123]. In these tissues,
positive staining for SCRIB was mostly detected in epithelial
cells [123]. SCRIB is also present in mouse eye and human
colon epithelia, along with DLG1 [131,132].
SCRIB (175 kDa) is a large cytoplasmic multidomain protein
that plays many roles in flies and mammals [39,41,129,133–
135]. SCRIB is a member of the LAP protein family, which also
includes Erbin [136], Densin180 [137] and Lano [138]. SCRIB
has 16 LRR at its N-terminal, followed by 2 LAP-specific
domains (LAPSD), a linker region, 4 PDZ domains and a
C-terminal lacking any identifiable motives [130] (Fig. 1).
Navarro et al. [123] have established that the LRR repeats
occurring in SCRIB determine its ability to target the basolateral
epithelial membranes.SCRIB binds directly to the C-terminal motif of ZO2 via its
PDZ domains 3 and 4 [139]. ZO2 interacts with several
components of the tight junctions, including ZO1, Occludin,
Cingulin and Claudins [140–142]. Metais et al. [139] detected a
partial pattern of colocalization between GFP-SCRIB and ZO2
at the cell junctions of unpolarized cells. SCRIB was not
colocalized with tight junction markers in polarized cells,
whereas it was colocalized with β-catenin, an adherens junction
marker [123]. The SCRIB/ZO2 interaction therefore probably
takes place at the cell junctions before ZO2 is segregated in the
tight junctions [139]. SCRIB and E-cadherin are mutually
dependent for their proper targeting to adherens junctions
[123,143]. Suppression of SCRIB expression in MDCK cells
causes a delay in tight junction assembly and affects the
epithelial morphology [143].
3.3.2. DLG
There exist five mammalian DLG proteins with molecular
weights ranging from 80 to 200 kDa. Mammalian family DLG
members show the characteristic MAGUK structural domains,
including three PDZ domains, a SH3 domain, a hook domain
(also known as 4.1 binding domain) and a GUK domain
(Fig. 1). In addition to this basic structure, DLG1 has a L27
domain at the N-terminal (as occurs in the case of Drosophila
Dlg), and DLG5 has a fourth PDZ domain and an extension
forming a coiled-coil structure at its N-terminal. We will focus
here on DLG1 because it is the most closely related to Droso-
phila Dlg and the most frequently studied DLG in epithelial
cells [144]. The authors detectedDLG1 transcripts in the human
brain, skeletal muscle, kidney, liver, cardiac muscle, and lung
tissue. In addition, DLG1 targets the basal membrane in in-
testinal cells [145].
The L27 domain of DLG1 is able to bind to MPP2, MPP3
[146], MPP7, Lin7 [147,148] and Lin2/hCask [149]. The
interaction between DLG1 and MPP7 facilitates epithelial tight
junction formation, and this complex combined with Lin7
regulates the stability of DLG1 and its distribution to cell
junctions [148]. Lin2/hCask is a calmodulin-associated Ser/Thr
kinase (Cask), another member of the MAGUK protein family,
and its association with DLG1 (via Cask L27N and DLG1
L27domains) is crucial to the lateral distribution of DLG1 in
MDCK cells [149]. In addition, the GUK domain of Cask is also
able to interact with the SH3 domain of DLG1 [121]. The lateral
localization of DLG1 may also depend on interaction with the
cytoskeleton protein 4.1, via PDZ 1 and 2 on DLG1 and a hook
domain [150]. The hook domains provide a link with the corti-
cal actin cytoskeleton after binding to members of the FERM
superfamily [151].
Matsumine et al. [152] described the occurrence of
interaction between PDZ domains of DLG1 and the C-terminal
region of adenomatous polyposis coli protein (APC) associated
with β-catenin. APC is mutated in familial adenomatous
polyposis and in sporadic colorectal tumors. In addition, APC
and DLG1 are colocalized in the basolateral membrane in rat
colon epithelial cells. The second PDZ of DLG1 interacts with
PTEN (protein tyrosine phosphatase and tensin homologue)
[153], and this link is disrupted by phosphorylation of the PTEN
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Tyrosine-phosphorylated DLG1 recruits PI3K (phosphoinosi-
tide 3-kinase) to the lateral membrane by interacting with the
SH2 domain of p85/PI3K in post-confluent differentiating
Caco2 cells [145]. Cells containing low levels of DLG1 (using
RNA interference method) fail to recruit PI3K to E-cadherin-
mediated cell–cell contacts and their cortical actin cytoskeleton
remains disorganized [154].
DLG1-deficient mice expressing a truncated DLG1 protein
lacking SH3, protein 4.1 and GUK domains show delayed
growth in utero and die perinatally [155,156]. The basolateral
localization of truncated DLG1 was altered and restricted to
the adherens junction, disrupting the epithelial polarity and the
process of nephrogenesis, due to either ureteral branching
morphogenesis and/or delayed mesenchyme-to-epithelial tran-
sition [156]. DLG1 is involved in regulating the structural
organization of the epithelial ducts during ontogeny [156].
Identification and characterization of GUK domain partners
will help to further elucidate the functional role of DLG1.
3.3.3. LGL
Two LGL proteins encoded by two different genes have been
identified in mammals, namely LGL1 (115 kDa) and LGL2
(113 kDa), which are homologous to the Lgl Drosophila protein
(Table 1). Two other related LGL proteins have been described
in mammals: syntaxin-binding protein 5 (LGL3, 120–130 kDa)
and syntaxin-binding protein-5-like (LGL4, 130 kDa) [157],
which are homologous to the Tomosyn Drosophila protein.
They all contain repeated WD40 domains: six in the case of
LGL1, LGL3 and LGL4, and five in the case of LGL2 (Fig. 1).
These WD40 repeats are known to form β-propellers that act as
protein interacting modules for SCRIB, but this point remains to
be further investigated, as Kallay et al. [128] have only
demonstrated it for LGL2. Among these four human LGL
genes, LGL1 and LGL2 have been the most thoroughly studied
to date [66,125], and we will therefore use LGL1/2 here to
denote both of these isoforms. LGL1 is expressed in the kidney
and brain, and LGL2 is expressed in the lung, brain and testis.
In the epithelia of vertebrates, LGL1/2 are localized to the
lateral membrane [66,125,128], the region below the adherens
junctions.
In MDCK epithelial cells, it has been reported that
overexpression of LGL1/2 during the polarity establishment
phase disrupts the formation of junctional complexes; whereas
its overexpression in confluent polarized cells has no such effect
[66]. Previously data indicated that LGL1/2 have to be
phosphorylated to be able to adopt its restricted basolateral
localization, as non-phosphorylatable LGL1/2 leaked into the
apical domain of MDCK cells [125]. This phosphorylation is
mediated by aPKC during the epithelial polarity establishment
phase [66,125], leading to the detachment of LGL1/2 from the
PAR6/aPKC dimer [66].
As LGL3 was found to exist in complex with the plasma
membrane protein t-SNARE syntaxin 1 in neuronal cells, and
since antibodies raised against LGL3 inhibit the exocytosis of
dense core vesicle, Musch et al. [125] suggested that LGL1 may
contribute to cell polarity by regulating polarized exocytosis inMDCK epithelial cells. LGL1 has in fact been found to interact
specifically with syntaxin4 (STX4) (a t-SNARE specific for
the lateral plasma membrane), which suggests that LGL may
contribute to apico-basal polarity by regulating basolateral
exocytosis [125].
4. Functional interactions between complexes and activation
The formation of a polarized epithelial cell layer with
functional tight junctions requires spatio-temporal coordination
of the activity of the polarity complexes. The three complexes
previously described in this review regulate the establishment
and maintenance of the apical polarity in the cell. However,
their localizations are distinct: CRB and PAR complexes are
restricted to the apical region of the lateral membrane whereas
SCRIB complex is concentrated along the lateral membrane.
In this part, we will review how the different polarity
complexes cooperate or interact together. It has by now been
clearly established that the three complexes are connected
through several protein–protein interactions. Genetic studies on
flies have shown that mutants for Scrib complex show opposite
phenotypes to those observed for mutants of members of the
Crb and Par complexes [39], which suggests that the basolateral
SCRIB complex and the apical CRB and PAR complexes have
antagonistic activities. A connection between these different
complexes was shown using genetic studies on flies and bio-
chemical studies on mammalian cells [39,158] (Fig. 2).
E-cadherin/E-cadherin interactions in the cell–cell adhesion
region trigger Cdc42-GTP activation [87] and the phosphory-
lation of aPKC, which in turn phosphorylates LGL. Phosphor-
ylated LGL dissociates from PAR6/aPKC dimer and distributes
to the lateral membrane, where it could interact with DLG and
SCRIB [85]. aPKC is then able to interact with and phosphor-
ylate PAR3, allowing the formation of the active PAR complex
at the apical junctions [69,159]. A direct connection therefore
exists between the activity of the basolateral complex contain-
ing LGL and the active apical PAR complex.
aPKC is required for the stable localization of PAR3, and
PAR3 phosphorylated at S827 residue accumulates at tight
junctions [84,160]. Once it has been phosphorylated at the S827
residue, PAR3 therefore dissociates from aPKC [84]. The
existence of this mechanism is supported by the fact that in
Drosophila Par1 phosphorylates Par3 inducing the fixation/
binding of the adaptor 14.3.3 protein, preventing the association
between Par3 and DmPar6/DaPkc dimer [161]. The kinase
domain of aPKC is then released and is free to phosphorylate
other proteins.
aPKC is able to bind directly to the CRB cytoplasmic tail that
contains two threonine residues (T6 and T9) in an evolutionarily
conserved region, which are potential targets for aPKC
phosphorylation. Interestingly, Dpatj is able to modulate the
phosphorylation of Crb by aPkc that is required for the proper
localization of aPkc and Dpatj to the apical membrane and that
of Scrib to the basolateral domain [162].
CRB3 binds to PAR6 directly [53] or via PALS1 [62], to
promote the differentiation of the premature junctional structure
into mature epithelial structures. In addition, overexpression of
Fig. 2. Polarity complex protein network in mammalian epithelial cells. This figure illustrates some of the many interactions that occur in epithelial cells. Colors show
the specific localization (cytosolic or membrane-associated) and function of the proteins.
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tight junctions [53,61], which strongly suggests that PAR6 and
CRB3 are involved in the same pathway, leading to the
formation of tight junctions. The existence of a relationship
between CRB complex and PAR complex has been further
supported by the finding that localization of aPKCζ to tight
junctions was inhibited in PALS1 siRNA expressing epithelial
cells [109], probably via the scaffold protein PAR6 that binds to
aPKC and PALS1. Interestingly, PAR3A was not mislocalized
in the PALS1 knock down cells, which suggests that PAR3A is
not recruited at the apical domain epithelial cells via PAR6, but
that it is rather anchored to junctional complexes by JAM
proteins present just below the CRB complex [71].
Furthermore, a study in Drosophila has reported that Dpatj
can interact directly with Dmpar6 providing another potential
mechanism linking the Crb to the Par complex [163]. In
contrast, Wang et al. in 2004 [63] have shown that at least in
MDCK epithelial cells, PAR6 binding to PALS1 interferes
with PATJ binding to PALS1, and that these interactions do
not work synergistically. The CRB-conserved ERLI motif
may therefore link CRB to the PAR complex via multiple
mechanisms.
In addition to interact with each others, these three complexes
have been found to interact with cytoskeleton-related proteins,
such as 14.3.3 protein for PAR complex [75], YMO1 (yurt/
mosaic eyes like 1) protein for CRB complex [164] and Myosin
II for SCRIB complex [165]. These interactions modulate the
dynamic of actin cytoskeleton, one of the key events controlling
cell shape and polarity.All these data suggest that the SCRIB complex restricts the
localization of CRB and PAR complexes to the apical region of
epithelial cells, where they may act together to regulate tight
junction formation.
5. Conclusion and perspectives
Although polarity complexes are involved in the formation
and maintenance of tight junctions in mammalian epithelial
cells, the exact mechanisms underlying their role are not yet
understood. In addition, these polarity complexes have been
found to be involved in other cellular events such as gene
expression, differentiation, motility and growth by the identi-
fication of new molecular interactions (Fig. 2).
Recently, new interactors have been identified like EHM2
(expressed in high-metastatic cell) and YMO1, which is also
known as EPB41L5 (erythrocyte protein band 4.1-like 5), which
interact in a FERM domain-dependent manner with CRB1,
CRB2 and CRB3 [164]. Their Drosophila homologue (Yurt)
acts as a negative regulator of Crb activity both in epithelial
polarity processes and at the apical membrane surface via a
mechanism that is not yet fully understood [164].
Wang et al. [110] recently reported that PALS1 is involved in
the regulation of E-cadherin trafficking. E-cadherin accumu-
lates in intracellular structures inside PALS1 knock down cells,
which indicates that the CRB complex might regulate the
recycling of adhesion molecules. The existence of link between
the CRB complex and vesicular trafficking agrees with the
finding that PATJ and MUPP1 bind to Angiomotin (Amot)
625E. Assémat et al. / Biochimica et Biophysica Acta 1778 (2008) 614–630[166], which is required (along with Rich1, a Cdc42-GAP) for
the targeting of PALS1 and PAR3 to the plasma membrane
[167]. Moreover in Drosophila, proteins involved in membrane
recycling such as Avalanche and Rab5 also contribute
importantly to the proper localization and functional integrity
of the Crb complex [168].
The occurrence of 10 and 13 PDZ domains in PATJ and
MUPP1, respectively, might indicate that many proteins other
than Claudins and JAM can be tethered to the tight junction
via MUPP1 and PATJ molecules. MUPP1 certainly interacts
via these domains with several molecules (Figs. 1 and 2),
including the proto-oncogene c-Kit [169], the transmembrane
proteoglycan NG2 [170], an adenovirus E4-ORF1 oncoprotein
[171], and Amot [166], which suggests the possible in-
volvement of MUPP1 and PATJ in growth, proliferation and
cell movement.
This hypothesis is in line with a recent interaction found to
occur between PATJ and the tuberous sclerosis complex 2
(TSC2 or Tuberin) protein [172]. TSC2 associated to TSC1
(Hamartin) forms a complex that regulates the mTOR cascade
through the GAP activity of TSC2 on Rheb, a small GTP-
binding protein [173]. PATJ binds to the last amino acids of
TSC2 via its PDZ domains 2 and 3, and depletion of PATJ from
human epithelial intestinal cells induced an upregulation of the
mTOR pathway, indicating that the CRB3 complex is able to
regulate the activity of TSC on the mTOR cascade [172]. This
finding opens new paths for understanding the role of the CRB
complex in the regulation of cell metabolism, size and survival.
SCRIB has been found to be involved in the recycling and
signaling of transmembrane receptor TSHR (thyroid stimulat-
ing hormone receptor) via the βPIX/GIT1/ARF6 pathway
[174]. The interactions occurring between SCRIB and members
of the Zyxin family (TRIP6 and LPP) have also suggested the
existence of a new communication pathway between cell con-
tact and the nucleus [175,176].
The PDZ domains of DLG interact with tumor suppressor
proteins, APC and PTEN, as well as with several viral
oncoproteins such as the E6 protein present in oncogenic
human papillomavirus (reviewed in [177]). It has been reported
that overexpression of DLG in fibroblasts impairs the events in
the G0/G1 to S phase and inhibits cell proliferation [178]. DLG,
like SCRIB, is therefore likely to be involved in the negative
regulation of cell proliferation [177]. The interaction between
APC and DLG regulated by PAR complex is involved in
polarized cell migration [179].
Mammalian LGL proteins are linked to the exocytic
machinery by direct interactions with SNARE proteins such as
Syntaxin [125,180,181]. Zhang et al. [181] proposed that
interactions between LGL proteins and the exocyst are important
for the establishment and reinforcement of cell polarity. LGL1 is
also associated with non-muscle heavy chain myosin II in a
cytoskeletal network [165].
In conclusion, epithelial polarity complexes act at several
cellular levels. PAR complex is required for defining the proper
apico-lateral axis via mechanisms that are probably conserved
between asymmetric cell division and establishment of epithelial
polarity. CRB and SCRIB complexes are essential to setting upand maintaining apical and lateral identities acting as opposite
forces. These effects may be mediated via the exo/endocytosis
pathways. All these complexes contribute to the formation of
apico-lateral junctions via mechanisms that are not yet
understood. One might speculate that the actin cortical cyto-
skeleton plays a fundamental role in this process. It is quite
certain, however, that polarity complexes also control cell
metabolism and proliferation, and research in this area will
predictably lead to some exciting new discoveries during the
next decade.
Acknowledgements
Our group is supported by the CNRS (UMR 6216), “La
Ligue Nationale Contre le Cancer” (équipe labellisée 2005), the
“Université de la Méditerranée” and “Cancéropôle Sud-Est”.
E. Assémat's fellowship was supported by “La Ligue Nationale
Contre le Cancer”. E. Bazellières and E. Pallesi-Pocachard are
recipients of a fellowship from the “Ministère français de la
recherche”.
References[1] D. Pruyne, A. Legesse-Miller, L. Gao, Y. Dong, A. Bretscher,
Mechanisms of polarized growth and organelle segregation in yeast,
Annu. Rev. Cell Dev. Biol. 20 (2004) 559–591.
[2] S.E. Siegrist, C.Q. Doe, Microtubule-induced cortical cell polarity, Genes
Dev. 21 (2007) 483–496.
[3] C.D. Stern, Evolution of the mechanisms that establish the embryonic
axes, Curr. Opin. Genet. Dev. 16 (2006) 413–418.
[4] N. Arimura, K. Kaibuchi, Neuronal polarity: from extracellular signals to
intracellular mechanisms, Nat. Rev., Neurosci. 8 (2007) 194–205.
[5] D. Delacour, R. Jacob, Apical protein transport, Cell. Mol. Life Sci. 63
(2006) 2491–2505.
[6] T. Watanabe, J. Noritake, K. Kaibuchi, Regulation of microtubules in cell
migration, Trends Cell Biol. 15 (2005) 76–83.
[7] M.F. Krummel, I. Macara, Maintenance and modulation of T cell polarity,
Nat. Immunol. 7 (2006) 1143–1149.
[8] K.J. Kemphues, J.R. Priess, D.G. Morton, N.S. Cheng, Identification of
genes required for cytoplasmic localization in early C. elegans embryos,
Cell 52 (1988) 311–320.
[9] J.E. Sulston, E. Schierenberg, J.G. White, J.N. Thomson, The embryonic
cell lineage of the nematode Caenorhabditis elegans, Dev. Biol. 100
(1983) 64–119.
[10] S. Strome, W.B. Wood, Immunofluorescence visualization of germ-line-
specific cytoplasmic granules in embryos, larvae, and adults of Caenor-
habditis elegans, Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 1558–1562.
[11] S. Strome, W.B. Wood, Generation of asymmetry and segregation of
germ-line granules in early C. elegans embryos, Cell 35 (1983) 15–25.
[12] S. Guo, K.J. Kemphues, par-1, A gene required for establishing polarity
in C. elegans embryos, encodes a putative Ser/Thr kinase that is
asymmetrically distributed, Cell 81 (1995) 611–620.
[13] J.L. Watts, D.G. Morton, J. Bestman, K.J. Kemphues, The C. elegans
par-4 gene encodes a putative serine-threonine kinase required for
establishing embryonic asymmetry, Development (Camb., Engl.) 127
(2000) 1467–1475.
[14] T.J. Hung, K.J. Kemphues, PAR-6 is a conserved PDZ domain-containing
protein that colocalizes with PAR-3 in Caenorhabditis elegans embryos,
Development (Camb., Engl.) 126 (1999) 127–135.
[15] B. Etemad-Moghadam, S. Guo, K.J. Kemphues, Asymmetrically
distributed PAR-3 protein contributes to cell polarity and spindle
alignment in early C. elegans embryos, Cell 83 (1995) 743–752.
[16] D.G. Morton, D.C. Shakes, S. Nugent, D. Dichoso, W. Wang, A. Golden,
626 E. Assémat et al. / Biochimica et Biophysica Acta 1778 (2008) 614–630K.J. Kemphues, TheCaenorhabditis elegans par-5 gene encodes a 14-3-3
protein required for cellular asymmetry in the early embryo, Dev. Biol.
241 (2002) 47–58.
[17] D.J. Levitan, L. Boyd, C.C.Mello, K.J. Kemphues, D.T. Stinchcomb, par-
2, A gene required for blastomere asymmetry in Caenorhabditis elegans,
encodes zinc-finger and ATP-binding motifs, Proc. Natl. Acad. Sci.
U. S. A. 91 (1994) 6108–6112.
[18] C.R. Cowan, A.A. Hyman, Asymmetric cell division in C. elegans:
cortical polarity and spindle positioning, Annu. Rev. Cell Dev. Biol. 20
(2004) 427–453.
[19] S. Guo, K.J. Kemphues, A non-muscle myosin required for embryonic
polarity in Caenorhabditis elegans, Nature 382 (1996) 455–458.
[20] L. Boyd, S. Guo, D. Levitan, D.T. Stinchcomb, K.J. Kemphues, PAR-2 is
asymmetrically distributed and promotes association of P granules and
PAR-1 with the cortex in C. elegans embryos, Development (Camb.,
Engl.) 122 (1996) 3075–3084.
[21] J.L. Watts, B. Etemad-Moghadam, S. Guo, L. Boyd, B.W. Draper, C.C.
Mello, J.R. Priess, K.J. Kemphues, par-6, A gene involved in the
establishment of asymmetry in early C. elegans embryos, mediates the
asymmetric localization of PAR-3, Development (Camb., Engl.) 122
(1996) 3133–3140.
[22] Y. Tabuse, Y. Izumi, F. Piano, K.J. Kemphues, J. Miwa, S. Ohno, Atypical
protein kinase C cooperates with PAR-3 to establish embryonic polarity
in Caenorhabditis elegans, Development (Camb., Engl.) 125 (1998)
3607–3614.
[23] U. Tepass, C. Theres, E. Knust, crumbs Encodes an EGF-like protein
expressed on apical membranes of Drosophila epithelial cells and
required for organization of epithelia, Cell 61 (1990) 787–799.
[24] G. Jürgens, E. Wieschaus, C. Nüsslein-Volhard, H. Kluding, Mutations
affecting the pattern of the larval cuticle in Drosophila melanogaster,
Dev. Genes Evol. 193 (1984) 283–295.
[25] A. Mazumdar, M. Mazumdar, How one becomes many: blastoderm
cellularization in Drosophila melanogaster, BioEssays 24 (2002)
1012–1022.
[26] A. Wodarz, F. Grawe, E. Knust, CRUMBS is involved in the control of
apical protein targeting during Drosophila epithelial development, Mech.
Dev. 44 (1993) 175–187.
[27] A. Wodarz, U. Hinz, M. Engelbert, E. Knust, Expression of crumbs
confers apical character on plasma membrane domains of ectodermal
epithelia of Drosophila, Cell 82 (1995) 67–76.
[28] A. Klebes, E. Knust, A conserved motif in Crumbs is required for E-
cadherin localisation and zonula adherens formation in Drosophila, Curr.
Biol. 10 (2000) 76–85.
[29] E. Medina, J. Williams, E. Klipfell, D. Zarnescu, G. Thomas, A. Le Bivic,
Crumbs interacts with moesin and beta(Heavy)-spectrin in the apical
membrane skeleton of Drosophila, J. Cell Biol. 158 (2002) 941–951.
[30] U. Tepass, E. Knust, Crumbs and stardust act in a genetic pathway that
controls the organization of epithelia in Drosophila melanogaster, Dev.
Biol. 159 (1993) 311–326.
[31] E. Knust, U. Tepass, A. Wodarz, crumbs and stardust, two genes of
Drosophila required for the development of epithelial cell polarity, Dev.
Suppl. (1993) 261–268.
[32] Y. Hong, B. Stronach, N. Perrimon, L.Y. Jan, Y.N. Jan, Drosophila
Stardust interacts with Crumbs to control polarity of epithelia but not
neuroblasts, Nature 414 (2001) 634–638.
[33] A. Bachmann, M. Schneider, E. Theilenberg, F. Grawe, E. Knust, Dro-
sophila Stardust is a partner of Crumbs in the control of epithelial cell
polarity, Nature 414 (2001) 638–643.
[34] M.A. Bhat, S. Izaddoost, Y. Lu, K.O. Cho, K.W. Choi, H.J. Bellen, Discs
Lost, a novel multi-PDZ domain protein, establishes and maintains
epithelial polarity, Cell 96 (1999) 833–845.
[35] J. Pielage, T. Stork, I. Bunse, C. Klambt, The Drosophila cell survival
gene discs lost encodes a cytoplasmic Codanin-1-like protein, not
a homolog of tight junction PDZ protein Patj, Dev. Cell 5 (2003)
841–851.
[36] S.C. Nam, K.W. Choi, Domain-specific early and late function of Dpatj in
Drosophila photoreceptor cells, Dev. Dyn. 235 (2006) 1501–1507.
[37] M.H. Roh, C.J. Liu, S. Laurinec, B. Margolis, The carboxyl terminus ofzona occludens-3 binds and recruits a mammalian homologue of discs
lost to tight junctions, J. Biol. Chem. 277 (2002) 27501–27509.
[38] M. Pellikka, G. Tanentzapf, M. Pinto, C. Smith, C.J. McGlade, D.F.
Ready, U. Tepass, Crumbs, the Drosophila homologue of human CRB1/
RP12, is essential for photoreceptor morphogenesis, Nature 416 (2002)
143–149.
[39] D. Bilder, N. Perrimon, Localization of apical epithelial determinants by
the basolateral PDZ protein Scribble, Nature 403 (2000) 676–680.
[40] D. Bilder, D. Birnbaum, J.P. Borg, P. Bryant, J. Huigbretse, E. Jansen,
M.B. Kennedy, M. Labouesse, R. Legouis, B. Mechler, N. Perrimon, M.
Petit, P. Sinha, Collective nomenclature for LAP proteins, Nat. Cell
Biol. 2 (2000) E114.
[41] D. Bilder, M. Li, N. Perrimon, Cooperative regulation of cell polarity
and growth by Drosophila tumor suppressors, Science New York, N.Y
289 (2000) 113–116.
[42] M.B. Stark, C.B. Bridges, The linkage relations of a benign tumor in
Drosophila, Genetics 11 (1926) 249–266.
[43] E. Gateff, The genetics and epigenetics of neoplasms in Drosophila, Biol.
Rev. Camb. Philos. Soc. 53 (1978) 123–168.
[44] B.M. Mechler, W. McGinnis, W.J. Gehring, Molecular cloning of lethal
(2)giant larvae, a recessive oncogene of Drosophila melanogaster,
EMBO J. 4 (1985) 1551–1557.
[45] R. Lutzelschwab, C. Klambt, R. Rossa, O. Schmidt, A protein product of
the Drosophila recessive tumor gene, l (2) giant gl, potentially has cell
adhesion properties, EMBO J. 6 (1987) 1791–1797.
[46] D.F. Woods, P.J. Bryant, The discs-large tumor suppressor gene of Dro-
sophila encodes a guanylate kinase homolog localized at septate junctions,
Cell 66 (1991) 451–464.
[47] M.B. Kennedy, Origin of PDZ (DHR, GLGF) domains, Trends Biochem.
Sci. 20 (1995) 350.
[48] K.O. Cho, C.A. Hunt, M.B. Kennedy, The rat brain postsynaptic density
fraction contains a homolog of the Drosophila discs-large tumor
suppressor protein, Neuron 9 (1992) 929–942.
[49] P.J. Bryant, K.L. Watson, R.W. Justice, D.F. Woods, Tumor suppressor
genes encoding proteins required for cell interactions and signal
transduction in Drosophila, Dev. Suppl. (1993) 239–249.
[50] K. Kemphues, PARsing embryonic polarity, Cell 101 (2000) 345–348.
[51] R. Bose, J.L. Wrana, Regulation of Par6 by extracellular signals, Curr.
Opin. Cell Biol. 18 (2006) 206–212.
[52] G. Joberty, C. Petersen, L. Gao, I.G.Macara, The cell-polarity protein Par6
links Par3 and atypical protein kinase C to Cdc42, Nat. Cell Biol. 2 (2000)
531–539.
[53] C. Lemmers, D. Michel, L. Lane-Guermonprez, M.H. Delgrossi, E.
Medina, J.P. Arsanto, A. Le Bivic, CRB3 binds directly to Par6 and
regulates the morphogenesis of the tight junctions in mammalian
epithelial cells, Mol. Biol. Cell 15 (2004) 1324–1333.
[54] D. Lin, A.S. Edwards, J.P. Fawcett, G. Mbamalu, J.D. Scott, T.
Pawson, A mammalian PAR-3-PAR-6 complex implicated in Cdc42/
Rac1 and aPKC signalling and cell polarity, Nat. Cell Biol. 2 (2000)
540–547.
[55] A.Y. Hung, M. Sheng, PDZ domains: structural modules for protein
complex assembly, J. Biol. Chem. 277 (2002) 5699–5702.
[56] S. Vinot, T. Le, B. Maro, S. Louvet-Vallee, Two PAR6 proteins become
asymmetrically localized during establishment of polarity in mouse
oocytes, Curr. Biol. 14 (2004) 520–525.
[57] S. Louvet-Vallee, S. Vinot, B. Maro, Mitotic spindles and cleavage planes
are oriented randomly in the two-cell mouse embryo, Curr. Biol. 15 (2005)
464–469.
[58] S. Vinot, T. Le, S. Ohno, T. Pawson, B. Maro, S. Louvet-Vallee,
Asymmetric distribution of PAR proteins in the mouse embryo begins at
the 8-cell stage during compaction, Dev. Biol. 282 (2005) 307–319.
[59] L. Gao, I.G. Macara, Isoforms of the polarity protein par6 have distinct
functions, J. Biol. Chem. 279 (2004) 41557–41562.
[60] A. Suzuki, S. Ohno, The PAR-aPKC system: lessons in polarity, J. Cell
Sci. 119 (2006) 979–987.
[61] L. Gao, G. Joberty, I.G. Macara, Assembly of epithelial tight junctions is
negatively regulated by Par6, Curr. Biol. 12 (2002) 221–225.
[62] T.W. Hurd, L. Gao, M.H. Roh, I.G. Macara, B. Margolis, Direct
627E. Assémat et al. / Biochimica et Biophysica Acta 1778 (2008) 614–630interaction of two polarity complexes implicated in epithelial tight
junction assembly, Nat. Cell Biol. 5 (2003) 137–142.
[63] Q. Wang, T.W. Hurd, B. Margolis, Tight junction protein Par6 interacts
with an evolutionarily conserved region in the amino terminus of PALS1/
stardust, J. Biol. Chem. 279 (2004) 30715–30721.
[64] S.M. Garrard, C.T. Capaldo, L. Gao, M.K. Rosen, I.G. Macara, D.R.
Tomchick, Structure of Cdc42 in a complex with the GTPase-binding
domain of the cell polarity protein, Par6, EMBO J. 22 (2003) 1125–1133.
[65] A. Johansson, M. Driessens, P. Aspenstrom, The mammalian homologue
of the Caenorhabditis elegans polarity protein PAR-6 is a binding partner
for the Rho GTPases Cdc42 and Rac1, J. Cell Sci. 113 (Pt 18) (2000)
3267–3275.
[66] T. Yamanaka, Y. Horikoshi, Y. Sugiyama, C. Ishiyama, A. Suzuki, T.
Hirose, A. Iwamatsu, A. Shinohara, S. Ohno, Mammalian Lgl forms a
protein complex with PAR-6 and aPKC independently of PAR-3 to
regulate epithelial cell polarity, Curr. Biol. 13 (2003) 734–743.
[67] M. Kohjima, Y. Noda, R. Takeya, N. Saito, K. Takeuchi, H. Sumimoto,
PAR3beta, a novel homologue of the cell polarity protein PAR3, localizes
to tight junctions, Biochem. Biophys. Res. Commun. 299 (2002)
641–646.
[68] L. Gao, I.G. Macara, G. Joberty, Multiple splice variants of Par3 and of a
novel related gene, Par3L, produce proteins with different binding
properties, Gene 294 (2002) 99–107.
[69] Y. Izumi, T. Hirose, Y. Tamai, S. Hirai, Y. Nagashima, T. Fujimoto, Y.
Tabuse, K.J. Kemphues, S. Ohno, An atypical PKC directly associates
and colocalizes at the epithelial tight junction with ASIP, a mammalian
homologue of Caenorhabditis elegans polarity protein PAR-3, J. Cell
Biol. 143 (1998) 95–106.
[70] K. Mizuno, A. Suzuki, T. Hirose, K. Kitamura, K. Kutsuzawa, M. Futaki,
Y. Amano, S. Ohno, Self-association of PAR-3-mediated by the
conserved N-terminal domain contributes to the development of epithelial
tight junctions, J. Biol. Chem. 278 (2003) 31240–31250.
[71] K. Ebnet, A. Suzuki, Y. Horikoshi, T. Hirose, M.K. Meyer Zu
Brickwedde, S. Ohno, D. Vestweber, The cell polarity protein ASIP/
PAR-3 directly associates with junctional adhesion molecule (JAM),
EMBO J. 20 (2001) 3738–3748.
[72] M. Itoh, H. Sasaki, M. Furuse, H. Ozaki, T. Kita, S. Tsukita, Junctional
adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the
recruitment of PAR-3 to tight junctions, J. Cell Biol. 154 (2001) 491–497.
[73] A. Suzuki, T. Yamanaka, T. Hirose, N. Manabe, K. Mizuno, M. Shimizu,
K. Akimoto, Y. Izumi, T. Ohnishi, S. Ohno, Atypical protein kinase C is
involved in the evolutionarily conserved par protein complex and plays a
critical role in establishing epithelia-specific junctional structures, J. Cell
Biol. 152 (2001) 1183–1196.
[74] X. Chen, I.G. Macara, RNA interference techniques to study epithelial
cell adhesion and polarity, Methods Enzymol. 406 (2006) 362–374.
[75] T.W. Hurd, S. Fan, C.J. Liu, H.K. Kweon, K. Hakansson, B. Margolis,
Phosphorylation-dependent binding of 14-3-3 to the polarity protein
Par3 regulates cell polarity in mammalian epithelia, Curr. Biol. 13 (2003)
2082–2090.
[76] Y. Wang, D. Du, L. Fang, G. Yang, C. Zhang, R. Zeng, A. Ullrich, F.
Lottspeich, Z. Chen, Tyrosine phosphorylated Par3 regulates epithelial
tight junction assembly promoted by EGFR signaling, EMBO J. 25 (2006)
5058–5070.
[77] X. Chen, I.G. Macara, Par-3 mediates the inhibition of LIM kinase 2 to
regulate cofilin phosphorylation and tight junction assembly, J. Cell Biol.
172 (2006) 671–678.
[78] A.E. Mertens, D.M. Pegtel, J.G. Collard, Tiam1 takes PARt in cell
polarity, Trends Cell Biol. 16 (2006) 308–316.
[79] L.A. Selbie, C. Schmitz-Peiffer, Y. Sheng, T.J. Biden, Molecular cloning
and characterization of PKC iota, an atypical isoform of protein kinase
C derived from insulin-secreting cells, J. Biol. Chem. 268 (1993)
24296–24302.
[80] Y. Ono, T. Fujii, K. Ogita, U. Kikkawa, K. Igarashi, Y. Nishizuka, Protein
kinase C zeta subspecies from rat brain: its structure, expression, and
properties, Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 3099–3103.
[81] Y. Hirano, S. Yoshinaga, K. Ogura,M. Yokochi, Y. Noda, H. Sumimoto, F.
Inagaki, Solution structure of atypical protein kinase C PB1 domain and itsmode of interaction with ZIP/p62 and MEK5, J. Biol. Chem. 279 (2004)
31883–31890.
[82] K. Akimoto, K. Mizuno, S. Osada, S. Hirai, S. Tanuma, K. Suzuki, S.
Ohno, A new member of the third class in the protein kinase C family,
PKC lambda, expressed dominantly in an undifferentiated mouse
embryonal carcinoma cell line and also in many tissues and cells, J.
Biol. Chem. 269 (1994) 12677–12683.
[83] J. Moscat, M.T. Diaz-Meco, The atypical protein kinase Cs. Functional
specificity mediated by specific protein adapters, EMBO Rep. 1 (2000)
399–403.
[84] Y. Nagai-Tamai, K. Mizuno, T. Hirose, A. Suzuki, S. Ohno, Regulated
protein–protein interaction between aPKC and PAR-3 plays an essential
role in the polarization of epithelial cells, Genes Cells 7 (2002)
1161–1171.
[85] P.J. Plant, J.P. Fawcett, D.C. Lin, A.D. Holdorf, K. Binns, S. Kulkarni, T.
Pawson, A polarity complex of mPar-6 and atypical PKC binds,
phosphorylates and regulates mammalian Lgl, Nat. Cell Biol. 5 (2003)
301–308.
[86] Y. Noda, R. Takeya, S. Ohno, S. Naito, T. Ito, H. Sumimoto, Human
homologues of the Caenorhabditis elegans cell polarity protein PAR6 as
an adaptor that links the small GTPases Rac and Cdc42 to atypical protein
kinase C, Genes Cells 6 (2001) 107–119.
[87] S.K. Kim, Cell polarity: new PARtners for Cdc42 and Rac, Nat. Cell Biol.
2 (2000) E143–E145.
[88] M.L. Standaert, G. Bandyopadhyay, L. Perez, D. Price, L. Galloway, A.
Poklepovic, M.P. Sajan, V. Cenni, A. Sirri, J. Moscat, A. Toker, R.V.
Farese, Insulin activates protein kinases C-zeta and C-lambda by an
autophosphorylation-dependent mechanism and stimulates their translo-
cation to GLUT4 vesicles and other membrane fractions in rat adipocytes,
J. Biol. Chem. 274 (1999) 25308–25316.
[89] S. Gopalakrishnan, M.A. Hallett, S.J. Atkinson, J.A. Marrs, aPKC-PAR
complex dysfunction and tight junction disassembly in renal epithelial
cells during ATP depletion, Am. J. Physiol. 292 (2007) C1094–C1102.
[90] E. Medina, C. Lemmers, L. Lane-Guermonprez, A. Le Bivic, Role of the
Crumbs complex in the regulation of junction formation in Drosophila
and mammalian epithelial cells, Biol. Cell 94 (2002) 305–313.
[91] A.I. denHollander, J.R. Heckenlively, L.I. van denBorn, Y.J. de Kok, S.D.
van der Velde-Visser, U. Kellner, B. Jurklies, M.J. van Schooneveld, A.
Blankenagel, K. Rohrschneider, B. Wissinger, J.R. Cruysberg, A.F.
Deutman, H.G. Brunner, E. Apfelstedt-Sylla, C.B. Hoyng, F.P. Cremers,
Leber congenital amaurosis and retinitis pigmentosa with Coats-like
exudative vasculopathy are associated with mutations in the crumbs
homologue 1 (CRB1) gene, Am. J. Hum. Genet. 69 (2001) 198–203.
[92] J.A. van den Hurk, P. Rashbass, R. Roepman, J. Davis, K.E. Voesenek,
M.L. Arends, M.N. Zonneveld, M.H. van Roekel, K. Cameron, K.
Rohrschneider, J.R. Heckenlively, R.K. Koenekoop, C.B. Hoyng, F.P.
Cremers, A.I. den Hollander, Characterization of the Crumbs homolog 2
(CRB2) gene and analysis of its role in retinitis pigmentosa and Leber
congenital amaurosis, Mol. Vis. 11 (2005) 263–273.
[93] V.C. Fogg, C.J. Liu, B. Margolis, Multiple regions of Crumbs3
are required for tight junction formation in MCF10A cells, J. Cell Sci.
118 (2005) 2859–2869.
[94] O. Makarova, M.H. Roh, C.J. Liu, S. Laurinec, B. Margolis, Mammalian
Crumbs3 is a small transmembrane protein linked to protein associated
with Lin-7 (Pals1), Gene 302 (2003) 21–29.
[95] A.I. den Hollander, J.B. ten Brink, Y.J. de Kok, S. van Soest, L.I. van den
Born, M.A. van Driel, D.J. van de Pol, A.M. Payne, S.S. Bhattacharya, U.
Kellner, C.B. Hoyng, A. Westerveld, H.G. Brunner, E.M. Bleeker-
Wagemakers, A.F. Deutman, J.R. Heckenlively, F.P. Cremers, A.A.
Bergen, Mutations in a human homologue of Drosophila crumbs cause
retinitis pigmentosa (RP12), Nat. Genet. 23 (1999) 217–221.
[96] M. Katoh, M. Katoh, Identification and characterization of Crumbs
homolog 2 gene at human chromosome 9q33.3, Int. J. Oncol. 24 (2004)
743–749.
[97] T.Watanabe, S. Miyatani, I. Katoh, S. Kobayashi, Y. Ikawa, Expression of
a novel secretory form (Crb1s) of mouse Crumbs homologue Crb1 in skin
development, Biochem. Biophys. Res. Commun. 313 (2004) 263–270.
[98] A.I. den Hollander, K. Johnson, Y.J. de Kok, A. Klebes, H.G. Brunner, E.
628 E. Assémat et al. / Biochimica et Biophysica Acta 1778 (2008) 614–630Knust, F.P. Cremers, CRB1 has a cytoplasmic domain that is functionally
conserved between human and Drosophila, Hum. Mol. Genet. 10 (2001)
2767–2773.
[99] C. Lemmers, E. Medina, M.H. Delgrossi, D. Michel, J.P. Arsanto, A. Le
Bivic, hINADl/PATJ, a homolog of discs lost, interacts with crumbs and
localizes to tight junctions in human epithelial cells, J. Biol. Chem. 277
(2002) 25408–25415.
[100] M. Richard, R. Roepman, W.M. Aartsen, A.G. van Rossum, A.I. den
Hollander, E. Knust, J. Wijnholds, F.P. Cremers, Towards understanding
CRUMBS function in retinal dystrophies, Hum.Mol. Genet. 15 (2) (2006)
R235–R243.
[101] A.H. Chishti, A.C. Kim, S.M. Marfatia, M. Lutchman, M. Hanspal, H.
Jindal, S.C. Liu, P.S. Low, G.A. Rouleau, N. Mohandas, J.A. Chasis, J.G.
Conboy, P. Gascard, Y. Takakuwa, S.C. Huang, E.J. Benz Jr., A.
Bretscher, R.G. Fehon, J.F. Gusella, V. Ramesh, F. Solomon, V.T.
Marchesi, S. Tsukita, S. Tsukita, K.B. Hoover, et al., The FERM domain:
a unique module involved in the linkage of cytoplasmic proteins to the
membrane, Trends Biochem. Sci. 23 (1998) 281–282.
[102] H. Yu, J.K. Chen, S. Feng, D.C. Dalgarno, A.W. Brauer, S.L. Schreiber,
Structural basis for the binding of proline-rich peptides to SH3 domains,
Cell 76 (1994) 933–945.
[103] M.H. Roh, B. Margolis, Composition and function of PDZ protein
complexes during cell polarization, Am. J. Physiol., Renal Fluid
Electrolyte Physiol. 285 (2003) F377–F387.
[104] S. Fan, T.W. Hurd, C.J. Liu, S.W. Straight, T. Weimbs, E.A. Hurd, S.E.
Domino, B. Margolis, Polarity proteins control ciliogenesis via kinesin
motor interactions, Curr. Biol. 14 (2004) 1451–1461.
[105] E. Kamberov, O. Makarova, M. Roh, A. Liu, D. Karnak, S. Straight, B.
Margolis, Molecular cloning and characterization of Pals, proteins
associated with mLin-7, J. Biol. Chem. 275 (2000) 11425–11431.
[106] M.H. Roh, O. Makarova, C.J. Liu, K. Shin, S. Lee, S. Laurinec, M.
Goyal, R. Wiggins, B. Margolis, The Maguk protein, Pals1, functions as
an adapter, linking mammalian homologues of Crumbs and Discs Lost,
J. Cell Biol. 157 (2002) 161–172.
[107] A.W. McGee, S.R. Dakoji, O. Olsen, D.S. Bredt, W.A. Lim, K.E.
Prehoda, Structure of the SH3-guanylate kinase module from PSD-95
suggests a mechanism for regulated assembly of MAGUK scaffolding
proteins, Mol. Cell 8 (2001) 1291–1301.
[108] G.A. Tavares, E.H. Panepucci, A.T. Brunger, Structural characterization
of the intramolecular interaction between the SH3 and guanylate kinase
domains of PSD-95, Mol. Cell 8 (2001) 1313–1325.
[109] S.W. Straight, K. Shin, V.C. Fogg, S. Fan, C.J. Liu, M. Roh, B. Margolis,
Loss of PALS1 expression leads to tight junction and polarity defects,
Mol. Biol. Cell 15 (2004) 1981–1990.
[110] Q. Wang, X.W. Chen, B. Margolis, PALS1 regulates E-cadherin
trafficking in mammalian epithelial cells, Mol. Biol. Cell 18 (2007)
874–885.
[111] D. Michel, J.P. Arsanto, D. Massey-Harroche, C. Beclin, J. Wijnholds, A.
Le Bivic, PATJ connects and stabilizes apical and lateral components of
tight junctions in human intestinal cells, J. Cell Sci. 118 (2005)
4049–4057.
[112] S. Philipp, V. Flockerzi, Molecular characterization of a novel human
PDZ domain protein with homology to INAD from Drosophila
melanogaster, FEBS Lett. 413 (1997) 243–248.
[113] C. Ullmer, K. Schmuck, A. Figge, H. Lubbert, Cloning and character-
ization of MUPP1, a novel PDZ domain protein, FEBS Lett. 424 (1998)
63–68.
[114] K. Matter, M.S. Balda, Occludin and the functions of tight junctions, Int.
Rev. Cyt. 186 (1999) 117–146.
[115] K. Shin, S. Straight, B. Margolis, PATJ regulates tight junction formation
and polarity in mammalian epithelial cells, J. Cell Biol. 168 (2005)
705–711.
[116] Y. Hamazaki, M. Itoh, H. Sasaki, M. Furuse, S. Tsukita, Multi-PDZ
domain protein 1 (MUPP1) is concentrated at tight junctions through its
possible interaction with claudin-1 and junctional adhesion molecule,
J. Biol. Chem. 277 (2002) 455–461.
[117] C.B. Coyne, T. Voelker, S.L. Pichla, J.M. Bergelson, The coxsackievirus
and adenovirus receptor interacts with the multi-PDZ domain protein-1(MUPP-1) within the tight junction, J. Biol. Chem. 279 (2004)
48079–48084.
[118] B. Jeansonne, Q. Lu, D.A. Goodenough, Y.H. Chen, Claudin-8 interacts
with multi-PDZ domain protein 1 (MUPP1) and reduces paracellular
conductance in epithelial cells, Cell. Mol. Biol. (Noisy-le-Grand, France)
49 (2003) 13–21.
[119] S. Poliak, S. Matlis, C. Ullmer, S.S. Scherer, E. Peles, Distinct claudins
and associated PDZ proteins form different autotypic tight junctions in
myelinating Schwann cells, J. Cell Biol. 159 (2002) 361–372.
[120] S.A. van de Pavert, A. Kantardzhieva, A. Malysheva, J. Meuleman, I.
Versteeg, C. Levelt, J. Klooster, S. Geiger, M.W. Seeliger, P. Rashbass, A.
Le Bivic, J. Wijnholds, Crumbs homologue 1 is required for maintenance
of photoreceptor cell polarization and adhesion during light exposure,
J. Cell Sci. 117 (2004) 4169–4177.
[121] S.L. Nix, A.H. Chishti, J.M. Anderson, Z. Walther, hCASK and hDlg
associate in epithelia, and their src homology 3 and guanylate kinase
domains participate in both intramolecular and intermolecular interac-
tions, J. Biol. Chem. 275 (2000) 41192–41200.
[122] A. Kantardzhieva, I. Gosens, S. Alexeeva, I.M. Punte, I. Versteeg, E.
Krieger, C.A. Neefjes-Mol, A.I. den Hollander, S.J. Letteboer, J. Klooster,
F.P. Cremers, R. Roepman, J. Wijnholds, MPP5 recruits MPP4 to the
CRB1 complex in photoreceptors, Invest. Ophthalmol. Vis. Sci. 46 (2005)
2192–2201.
[123] C. Navarro, S. Nola, S. Audebert, M.J. Santoni, J.P. Arsanto, C. Ginestier,
S. Marchetto, J. Jacquemier, D. Isnardon, A. Le Bivic, D. Birnbaum, J.P.
Borg, Junctional recruitment of mammalian Scribble relies on E-cadherin
engagement, Oncogene 24 (2005) 4330–4339.
[124] B.M. Muller, U. Kistner, R.W. Veh, C. Cases-Langhoff, B. Becker, E.D.
Gundelfinger, C.C. Garner, Molecular characterization and spatial
distribution of SAP97, a novel presynaptic protein homologous to
SAP90 and the Drosophila discs-large tumor suppressor protein,
J. Neurosci. 15 (1995) 2354–2366.
[125] A. Musch, D. Cohen, C. Yeaman, W.J. Nelson, E. Rodriguez-Boulan, P.J.
Brennwald, Mammalian homolog of Drosophila tumor suppressor lethal
(2) giant larvae interacts with basolateral exocytic machinery in Madin-
Darby canine kidney cells, Mol. Biol. Cell 13 (2002) 158–168.
[126] D. Mathew, L.S. Gramates, M. Packard, U. Thomas, D. Bilder, N.
Perrimon, M. Gorczyca, V. Budnik, Recruitment of scribble to the
synaptic scaffolding complex requires GUK-holder, a novel DLG binding
protein, Curr. Biol. 12 (2002) 531–539.
[127] M. Katoh, M. Katoh, Identification and characterization of human
GUKH2 gene in silico, Int. J. Oncol. 24 (2004) 1033–1038.
[128] L.M. Kallay, A. McNickle, P.J. Brennwald, A.L. Hubbard, L.T. Braiter-
man, Scribble associates with two polarity proteins, Lgl2 and Vangl2, via
distinct molecular domains, J. Cell. Biochem. 99 (2006) 647–664.
[129] S. Nakagawa, J.M. Huibregtse, Human scribble (Vartul) is targeted for
ubiquitin-mediated degradation by the high-risk papillomavirus E6
proteins and the E6AP ubiquitin-protein ligase, Mol. Cell. Biol. 20
(2000) 8244–8253.
[130] M.J. Santoni, P. Pontarotti, D. Birnbaum, J.P. Borg, The LAP family: a
phylogenetic point of view, Trends Genet. 18 (2002) 494–497.
[131] M.M. Nguyen, C. Rivera, A.E. Griep, Localization of PDZ domain
containing proteins Discs Large-1 and Scribble in the mouse eye, Mol.
Vis. 11 (2005) 1183–1199.
[132] D. Gardiol, A. Zacchi, F. Petrera, G. Stanta, L. Banks, Human discs
large and scrib are localized at the same regions in colon mucosa and
changes in their expression patterns are correlated with loss of tissue
architecture during malignant progression, Int. J. Cancer 119 (2006)
1285–1290.
[133] S. Nakagawa, T. Yano, K. Nakagawa, S. Takizawa, Y. Suzuki, T. Yasugi,
J.M. Huibregtse, Y. Taketani, Analysis of the expression and localisation
of a LAP protein, human scribble, in the normal and neoplastic epithelium
of uterine cervix, Br. J. Cancer 90 (2004) 194–199.
[134] J.N. Murdoch, D.J. Henderson, K. Doudney, C. Gaston-Massuet, H.M.
Phillips, C. Paternotte, R. Arkell, P. Stanier, A.J. Copp, Disruption of
scribble (Scrb1) causes severe neural tube defects in the circletail mouse,
Hum. Mol. Genet. 12 (2003) 87–98.
[135] C. Segbert, K. Johnson, C. Theres, D. van Furden, O. Bossinger,
629E. Assémat et al. / Biochimica et Biophysica Acta 1778 (2008) 614–630Molecular and functional analysis of apical junction formation in the gut
epithelium of Caenorhabditis elegans, Dev. Biol. 266 (2004) 17–26.
[136] J.P. Borg, S. Marchetto, A. Le Bivic, V. Ollendorff, F. Jaulin-Bastard, H.
Saito, E. Fournier, J. Adelaide, B. Margolis, D. Birnbaum, ERBIN: a
basolateral PDZ protein that interacts with the mammalian ERBB2/HER2
receptor, Nat. Cell Biol. 2 (2000) 407–414.
[137] S. Strack, A.J. Robison, M.A. Bass, R.J. Colbran, Association of calcium/
calmodulin-dependent kinase II with developmentally regulated splice
variants of the postsynaptic density protein densin-180, J. Biol. Chem.
275 (2000) 25061–25064.
[138] H. Saito, M.J. Santoni, J.P. Arsanto, F. Jaulin-Bastard, A. Le Bivic, S.
Marchetto, S. Audebert, D. Isnardon, J. Adelaide, D. Birnbaum, J.P.
Borg, Lano, a novel LAP protein directly connected to MAGUK proteins
in epithelial cells, J. Biol. Chem. 276 (2001) 32051–32055.
[139] J.Y. Metais, C. Navarro, M.J. Santoni, S. Audebert, J.P. Borg, hScrib
interacts with ZO-2 at the cell–cell junctions of epithelial cells, FEBS
Lett. 579 (2005) 3725–3730.
[140] B. Gumbiner, T. Lowenkopf, D. Apatira, Identification of a 160-kDa
polypeptide that binds to the tight junction protein ZO-1, Proc. Natl.
Acad. Sci. U. S. A. 88 (1991) 3460–3464.
[141] M. Itoh, M. Furuse, K. Morita, K. Kubota, M. Saitou, S. Tsukita, Direct
binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and
ZO-3, with the COOH termini of claudins, J. Cell Biol. 147 (1999)
1351–1363.
[142] M. Cordenonsi, F. D'Atri, E. Hammar, D.A. Parry, J. Kendrick-Jones, D.
Shore, S. Citi, Cingulin contains globular and coiled-coil domains and
interacts with ZO-1, ZO-2, ZO-3, and myosin, J. Cell Biol. 147 (1999)
1569–1582.
[143] Y. Qin, C. Capaldo, B.M. Gumbiner, I.G. Macara, The mammalian
Scribble polarity protein regulates epithelial cell adhesion and migration
through E-cadherin, J. Cell Biol. 171 (2005) 1061–1071.
[144] M. McLaughlin, R. Hale, D. Ellston, S. Gaudet, R.A. Lue, A. Viel, The
distribution and function of alternatively spliced insertions in hDlg,
J. Biol. Chem. 277 (2002) 6406–6412.
[145] P. Laprise, A. Viel, N. Rivard, Human homolog of disc-large is required
for adherens junction assembly and differentiation of human intestinal
epithelial cells, J. Biol. Chem. 279 (2004) 10157–10166.
[146] D. Karnak, S. Lee, B. Margolis, Identification of multiple binding
partners for the amino-terminal domain of synapse-associated protein 97,
J. Biol. Chem. 277 (2002) 46730–46735.
[147] V.M. Stucke, E. Timmerman, J. Vandekerckhove, K. Gevaert, A. Hall,
The MAGUK protein MPP7 binds to the polarity protein hDlg1 and
facilitates epithelial tight junction formation, Mol. Biol. Cell 18 (2007)
1744–1755.
[148] J. Bohl, N. Brimer, C. Lyons, S.B. Vande Pol, The stardust family protein
MPP7 forms a tripartite complex with LIN7 and DLG1 that regulates
the stability and localization of DLG1 to cell junctions, J. Biol. Chem.
282 (2007) 9392–9400.
[149] S. Lee, S. Fan, O. Makarova, S. Straight, B. Margolis, A novel and
conserved protein–protein interaction domain of mammalian Lin-2/
CASK binds and recruits SAP97 to the lateral surface of epithelia, Mol.
Cell. Biol. 22 (2002) 1778–1791.
[150] R.A. Lue, E. Brandin, E.P. Chan, D. Branton, Two independent domains
of hDlg are sufficient for subcellular targeting: the PDZ1–2 conforma-
tional unit and an alternatively spliced domain, J. Cell Biol. 135 (1996)
1125–1137.
[151] W. Nunomura, Y. Takakuwa, M. Parra, J. Conboy, N. Mohandas,
Regulation of protein 4.1R, p55, and glycophorin C ternary complex in
human erythrocyte membrane, J. Biol. Chem. 275 (2000) 24540–24546.
[152] A. Matsumine, A. Ogai, T. Senda, N. Okumura, K. Satoh, G.H. Baeg, T.
Kawahara, S. Kobayashi, M. Okada, K. Toyoshima, T. Akiyama, Binding
of APC to the human homolog of the Drosophila discs large tumor
suppressor protein, Science New York, N.Y 272 (1996) 1020–1023.
[153] N.B. Adey, L. Huang, P.A. Ormonde, M.L. Baumgard, R. Pero, D.V.
Byreddy, S.V. Tavtigian, P.L. Bartel, Threonine phosphorylation of the
MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ
binding, Cancer Res. 60 (2000) 35–37.
[154] P. Laprise, P. Chailler, M. Houde, J.F. Beaulieu, M.J. Boucher, N. Rivard,Phosphatidylinositol 3-kinase controls human intestinal epithelial cell
differentiation by promoting adherens junction assembly and p38 MAPK
activation, J. Biol. Chem. 277 (2002) 8226–8234.
[155] G. Caruana, A. Bernstein, Craniofacial dysmorphogenesis including cleft
palate in mice with an insertional mutation in the discs large gene, Mol.
Cell. Biol. 21 (2001) 1475–1483.
[156] A. Iizuka-Kogo, T. Ishidao, T. Akiyama, T. Senda, Abnormal
development of urogenital organs in Dlgh1-deficient mice, Development
(Camb., Engl.) 134 (2007) 1799–1807.
[157] M. Katoh, M. Katoh, Identification and characterization of human
LLGL4 gene and mouse Llgl4 gene in silico, Int. J. Oncol. 24 (2004)
737–742.
[158] B. Margolis, J.P. Borg, Apicobasal polarity complexes, J. Cell Sci. 118
(2005) 5157–5159.
[159] T. Hirose, Y. Izumi, Y. Nagashima, Y. Tamai-Nagai, H. Kurihara, T. Sakai,
Y. Suzuki, T. Yamanaka, A. Suzuki, K. Mizuno, S. Ohno, Involvement of
ASIP/PAR-3 in the promotion of epithelial tight junction formation, J. Cell
Sci. 115 (2002) 2485–2495.
[160] A. Suzuki, C. Ishiyama, K. Hashiba, M. Shimizu, K. Ebnet, S. Ohno,
aPKC kinase activity is required for the asymmetric differentiation of the
premature junctional complex during epithelial cell polarization, J. Cell
Sci. 115 (2002) 3565–3573.
[161] R. Benton, D. St Johnston, Drosophila PAR-1 and 14-3-3 inhibit
Bazooka/PAR-3 to establish complementary cortical domains in
polarized cells, Cell 115 (2003) 691–704.
[162] S. Sotillos, M.T. Diaz-Meco, E. Caminero, J. Moscat, S. Campuzano,
DaPKC-dependent phosphorylation of Crumbs is required for epithelial
cell polarity in Drosophila, J. Cell Biol. 166 (2004) 549–557.
[163] S.C. Nam, K.W. Choi, Interaction of Par-6 and Crumbs complexes is
essential for photoreceptor morphogenesis in Drosophila, Development
(Camb., Engl.) 130 (2003) 4363–4372.
[164] P. Laprise, S. Beronja, N.F. Silva-Gagliardi, M. Pellikka, A.M. Jensen,
C.J. McGlade, U. Tepass, The FERM protein Yurt is a negative regulatory
component of the Crumbs complex that controls epithelial polarity and
apical membrane size, Dev. Cell 11 (2006) 363–374.
[165] D. Strand, S. Unger, R. Corvi, K. Hartenstein, H. Schenkel, A. Kalmes,
G. Merdes, B. Neumann, F. Krieg-Schneider, J.F. Coy, et al., A human
homologue of the Drosophila tumour suppressor gene l(2)gl maps to
17p11.2–12 and codes for a cytoskeletal protein that associates with
nonmuscle myosin II heavy chain, Oncogene 11 (1995) 291–301.
[166] Y. Sugihara-Mizuno, M. Adachi, Y. Kobayashi, Y. Hamazaki, M.
Nishimura, T. Imai, M. Furuse, S. Tsukita, Molecular characterization of
angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their
endogenous properties, Genes Cells 12 (2007) 473–486.
[167] C.D. Wells, J.P. Fawcett, A. Traweger, Y. Yamanaka, M. Goudreault, K.
Elder, S. Kulkarni, G. Gish, C. Virag, C. Lim, K. Colwill, A. Starostine, P.
Metalnikov, T. Pawson, A Rich1/Amot complex regulates the Cdc42
GTPase and apical-polarity proteins in epithelial cells, Cell 125 (2006)
535–548.
[168] H. Lu, D. Bilder, Endocytic control of epithelial polarity and proliferation
in Drosophila, Nat. Cell Biol. 7 (2005) 1232–1239.
[169] A. Mancini, A. Koch, M. Stefan, H. Niemann, T. Tamura, The direct
association of the multiple PDZ domain containing proteins (MUPP-1)
with the human c-Kit C-terminus is regulated by tyrosine kinase activity,
FEBS Lett. 482 (2000) 54–58.
[170] D.S. Barritt, M.T. Pearn, A.H. Zisch, S.S. Lee, R.T. Javier, E.B. Pasquale,
W.B. Stallcup, The multi-PDZ domain protein MUPP1 is a cytoplasmic
ligand for the membrane-spanning proteoglycan NG2, J. Cell. Biochem.
79 (2000) 213–224.
[171] S.S. Lee, B. Glaunsinger, F. Mantovani, L. Banks, R.T. Javier, Multi-PDZ
domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1
and high-risk papillomavirus type 18 E6 oncoproteins, J. Virol. 74 (2000)
9680–9693.
[172] D. Massey-Harroche, M.H. Delgrossi, L. Lane-Guermonprez, J.P.
Arsanto, J.P. Borg, M. Billaud, A. Le Bivic, Evidence for a molecular
link between the tuberous sclerosis complex and the Crumbs complex,
Hum. Mol. Genet. 16 (2007) 529–536.
[173] J. Avruch, K. Hara, Y. Lin, M. Liu, X. Long, S. Ortiz-Vega, K. Yonezawa,
630 E. Assémat et al. / Biochimica et Biophysica Acta 1778 (2008) 614–630Insulin and amino-acid regulation of mTOR signaling and kinase activity
through the Rheb GTPase, Oncogene 25 (2006) 6361–6372.
[174] O. Lahuna, M. Quellari, C. Achard, S. Nola, G. Meduri, C. Navarro, N.
Vitale, J.P. Borg, M. Misrahi, Thyrotropin receptor trafficking relies on
the hScrib-betaPIX-GIT1-ARF6 pathway, EMBO J. 24 (2005)
1364–1374.
[175] M.M. Petit, K.R. Crombez, H.B. Vervenne, N. Weyns, W.J. Van de Ven,
The tumor suppressor Scrib selectively interacts with specific members of
the zyxin family of proteins, FEBS Lett. 579 (2005) 5061–5068.
[176] M.M. Petit, S.M. Meulemans, P. Alen, T.A. Ayoubi, E. Jansen, W.J. Van
de Ven, The tumor suppressor Scrib interacts with the zyxin-related
protein LPP, which shuttles between cell adhesion sites and the nucleus,
BMC Cell Biol. 6 (2005) 1.
[177] P. Humbert, S. Russell, H. Richardson, Dlg, Scribble and Lgl in cell
polarity, cell proliferation and cancer, BioEssays 25 (2003) 542–553.
[178] T. Ishidate, A. Matsumine, K. Toyoshima, T. Akiyama, The APC-hDLG
complex negatively regulates cell cycle progression from the G0/G1 to S
phase, Oncogene 19 (2000) 365–372.
[179] S. Etienne-Manneville, J.B.Manneville, S. Nicholls,M.A. Ferenczi, A. Hall,
Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1
and APC to control cell polarization, J. Cell Biol. 170 (2005) 895–901.
[180] A. Gangar, G. Rossi, A. Andreeva, R. Hales, P. Brennwald, Structurally
conserved interaction of Lgl family with SNAREs is critical to their
cellular function, Curr. Biol. 15 (2005) 1136–1142.
[181] X. Zhang, P. Wang, A. Gangar, J. Zhang, P. Brennwald, D. TerBush, W.
Guo, Lethal giant larvae proteins interact with the exocyst complex and
are involved in polarized exocytosis, J. Cell Biol. 170 (2005) 273–283.
[182] B. Ozdamar, R. Bose,M. Barrios-Rodiles, H.R.Wang, Y. Zhang, J.L.Wrana,Regulation of the polarity protein Par6 by TGFbeta receptors controls
epithelial cell plasticity, Science New York, N.Y 307 (2005) 1603–1609.
[183] X.F. Liu, H. Ishida, R. Raziuddin, T. Miki, Nucleotide exchange factor
ECT2 interacts with the polarity protein complex Par6/Par3/protein
kinase Czeta (PKCzeta) and regulates PKCzeta activity, Mol. Cell. Biol.
24 (2004) 6665–6675.
[184] T. Nishimura, K. Kato, T. Yamaguchi, Y. Fukata, S. Ohno, K. Kaibuchi,
Role of the PAR-3-KIF3 complex in the establishment of neuronal
polarity, Nat. Cell Biol. 6 (2004) 328–334.
[185] G. Krapivinsky, I. Medina, L. Krapivinsky, S. Gapon, D.E. Clapham,
SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase
activity and NMDA receptor-dependent synaptic AMPA receptor
potentiation, Neuron 43 (2004) 563–574.
[186] W.A. Kimber, L. Trinkle-Mulcahy, P.C. Cheung,M. Deak, L.J.Marsden, A.
Kieloch, S. Watt, R.T. Javier, A. Gray, C.P. Downes, J.M. Lucocq, D.R.
Alessi, Evidence that the tandem-pleckstrin-homology-domain-containing
protein TAPP1 interacts with Ptd(3,4)P2 and the multi-PDZ-domain-
containing protein MUPP1 in vivo, Biochem. J. 361 (2002) 525–536.
[187] S. Dakoji, S. Tomita, S. Karimzadegan, R.A. Nicoll, D.S. Bredt,
Interaction of transmembrane AMPA receptor regulatory proteins with
multiple membrane associated guanylate kinases, Neuropharmacology
45 (2003) 849–856.
[188] N. Griffon, F. Jeanneteau, F. Prieur, J. Diaz, P. Sokoloff, CLIC6, a
member of the intracellular chloride channel family, interacts with
dopamine D(2)-like receptors, Brain Res. 117 (2003) 47–57.
[189] F.J. Tejedor, A. Bokhari, O. Rogero, M. Gorczyca, J. Zhang, E. Kim, M.
Sheng, V. Budnik, Essential role for dlg in synaptic clustering of Shaker
K+ channels in vivo, J. Neurosci. 17 (1997) 152–159.
